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A new synthetic route has been explored for the preparation of derivatives of 2-acetamido-2-deoxy-L-
altruronic acid (L-AltNAcA). This is a rare sugar found together with 2-acetamido-4-amino-2,4-dideoxy-
D-fucose(D-FucNAc4N) in the repeating unit of Shigella sonnei. Derivatives are needed inter alia for 
chemical and spectroscopic calibration standards, and as building blocks for preparing oligomeric 
subunits of the O-polysaccharide antigen for possible incorporation into a synthetic glycoconjugate 
vaccine. Two synthetic routes were investigated. The first route successfully repeated a published four 
step sequence converting diacetone-D-glucose to 1,6-anhydro--L-idopyranose in a 38%  yield overall, 
and a further selective benzylation at O-3. Attempts to discriminate between O-2, O-3 and O-4 using low 
temperature acylation or alkylation conditions were unsuccessful, but modest selectivity for the 4-
benzoate was observed in a Bu2SnO-mediated benzoylation, although this product could not be easily 
separated from other mono-benzoates. The second route started from N-acetyl-D-glucosamine which 
was successfully converted in the first step to 2-methyl-(1,2-dideoxyl-5,6-O-isopropylidene--D-
glucofurano)-[2,1-d]-2-oxazoline. The oxazoline and dioxolane units could be selectively manipulated 
in a series of steps to afford 2-acetamido-2-deoxy-3-O-benzyl-6-O-t-butyldimethylsilyl--D-
glucofuranosyl acetate in a 41% yield over four steps. This is a key synthetic intermediate in which the 
5-OH is available for the required inversion step. During this study, 
 an unusual minor side-product, 1,6-anhydro-2-acetamido-O-acetyl-2-deoxy-3-O-benzyl--D-
glucofuranose, was isolated. While this was also a potentially useful intermediate, having only the  
5-OH unprotected, it proved not possible to find conditions for optimizing this product. Inversion of 
configuration at C-5 in the 6-O-silylated glucofuranose was attempted via the 5-O-triflate and 5-O-
mesylate: the triflate formed but was displaced in situ by the solvent pyridine to give an unusual 5-
pyridinium derivative, while the mesylate was stable but unreactive towards subsequent SN2 inversion. 
These outcomes were attributed to the steric congestion imposed by the combination of the 3,4-cis-
disubstitution of the furanose ring and the very bulky silyl substituent at O-6. While the goal of preparing 
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1.1 Carbohydrates in Nature 
Carbohydrates are one of the four essential building blocks of life.1 In their simplest form they exist as 
monomers known as monosaccharides. D-Glucose is the most common monosaccharide and the most 
abundant organic molecule on earth.2 Monosaccharides link together through glycosidic bonds to form 
oligosaccharides (2-10) and polysaccharides (>10). Apart from being one of our main energy sources, 
carbohydrates are vital structural components in nature, forming part of DNA, RNA, starch, cellulose 
and cotton.3 These versatile molecules are also involved in biological signalling and recognition 
processes through interactions with cell surfaces. The carbohydrates expressed on the surface of 
pathogens enable them to evade humans’ innate immune response. However, cell surface recognition 
binding stimulates the adaptive immune system which elicits an immune response against the pathogen. 
Consequently, carbohydrates form the basis of many vaccines.4 Research into the synthesis of 
biologically relevant carbohydrates is therefore of great importance in the prevention of diseases.  
 
1.2 Shigella sonnei 
Diarrhoeal diseases account for approximately 1.5 million deaths annually predominantly affecting low-
middle income countries.5,6  Dysentery due to shigellosis is responsible for 1.1 million of those deaths. 
It consistently ranks in the WHO top 10 causes of death in developing countries with 60% of those 
deaths in children under 5 years old.7,8 Shigellosis is a bacterial infection of the mucosal epithelial cells 
in the small intestine.9 It is caused by the bacteria of the genus Shigella, which is divided into four 
serogroups; S. dystenteriae, S. flexneri, S. boydii and S. sonnei.10 77% of infections in industrialized 
countries are caused by S. sonnei9,11 and this serogroup was the focus of this study. 
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Shigellosis is a waterborne disease and is primarily transmitted through faecal-oral contamination.12 
Poor hygiene and limited sanitation in addition to the low infectious dose make this disease highly 
prevalent in low income developing countries.13 Shigellosis  is one of the many opportunistic infections 
that occur in HIV and AIDS patients which is of great concern particularly in Africa.8,9,11,14 Further studies 
have also shown that the effects of Shigellosis are not only short term but can cause physical and 
cognitive impairments in the long term.15,16 
 
Recent reports have shown that the mortality rate due to diarrhoea has decreased from effective 
treatments with zinc, fluid replacement and improvement of general hygiene such as hand washing.5,6 
Antimicrobial drugs have also been very effective in reducing the spread of the infection, duration of 
diarrhoea and fevers.17 However, the disease severity and antibiotic resistance are ever growing 
challenges especially for children under 5 years.18,19 Increased resistance to antibiotics such as 
ciprofloxacin, pivmecillinam, azithromycin and cephalosporins has encouraged investigation into 
vaccines as the primary form of prevention.10 Many investigations into the pathogenesis of shigellosis 
and elicited immune response have formed the basis of vaccine requirements.  
 
1.3 Vaccine Development 
Shigella cells contain a bacterial surface antigen, the 
lipopolysaccharide (LPS), which allows the invasion of numerous 
host cells.10  The LPS contains an O-specific polysaccharide chain 
(O-SP), which is made up of repeating unit such as the 
disaccharide in the O-SP from S. sonnei, shown in Figure 1. It is this 
repeating unit that varies and gives rise to different serotypes in 
the aforementioned serogroups of Shigella. Robbins et al.20,21 identified that this serotype-specific O-SP 
chain plays an essential role in eliciting an immune response and is therefore a key virulence factor 
which can be exploited in vaccines development. However, it does not stimulate a strong immune 
D-FucNAc4N L-AltNAcA
   
  
Figure 1: Repeating unit of S. sonnei 
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response22 and requires covalent linkage to a carrier protein to become immunogenic.23 The covalently 




1.4 Conjugate Vaccines 
In the last 5 years major breakthroughs with conjugate vaccines have shown potential to produce a safe 
and effective solution to shigellosis. GlycoVaxyn, a biopharmaceutical company, is currently 
investigating the development of a multivalent conjugate vaccine against the five most common 
serotypes of Shigella: S. sonnei, S. dysenteriae O1, S. flexneri 2a, S. flexneri 3a and S. flexneri 6. A potential 
candidate against S. dysenteriae O1 has performed well in a Phase I clinical trial24 and a candidate for S. 
flexneri 2a is currently in clinical trials.  
 
GlycoVaxyn’s technology makes use of a bioconjugation platform to produce conjugate vaccines in 
bacterial cells, avoiding chemical conjugation.25,26 This exploits recombinant DNA techniques to modify 
E. coli bacteria to reproducibly manufacture specific glycoproteins.27 The technology enables almost any 
bacterial polysaccharide to be conjugated to almost any bacterial protein.26,28 This technology allows the 
challenges of current methods for conjugate vaccine production to be avoided through a simplified 
biological process which lowers production costs and improves efficiency.26,28  
 
Since this method produces the vaccine in one process, the protein and carbohydrate constituents are 
not able to be analysed independently. Authentic samples of the monosaccharides, which are not 
commercially available, are therefore needed as chemical and spectroscopic calibration standards for 
Figure 2: Showing the carbohydrate component of the potential glycoconjugate vaccine and its source in S. sonnei 
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use in physicochemical and biological assays. This is essential for the analysis and verification of the 
carbohydrate component of the conjugate vaccine.  
 
1.5 Synthesis of the Disaccharide Repeating Unit of S. sonnei 
Synthesis of the any oligosaccharide repeating unit, such as that of S. sonnei (Figure 1), involves 
synthesising each monosaccharide in a suitably protected form, followed by formation of the glycosidic 
linkages in the correct sequence. It is therefore essential that each monosaccharide can be suitably 
activated at the anomeric position to act as a glycosyl donor, and have a selectively removable protecting 
group at the hydroxyl group where it will form the glycosidic bond. Accordingly, the protected forms of 
D-FucNAc4N and L-AltNAcA are the first target compounds towards the synthesis of the repeating unit. 
Sugars in the D-configuration, such as D-FucNAc4N, are generally accessible from abundant D-sugar 
precursors, whereas the L-sugar, L-AltNAcA, has to be prepared from much rarer and more expensive L-
sugars, or via challenging routes from the D-sugars. There are only two successful methods reported for 
the total syntheses of L-AltNAcA,29,30 both starting from sugars already in the L-configuration, thus 
reducing the synthetic challenges although increasing production costs. The published synthetic routes 
to these unusual sugars are briefly reviewed here as to provide context for the present study. 
 
1.5.1 Synthesis of D-FucNAc4N 
This monosaccharide has been successfully synthesised by a number of groups in various protected 
forms.30–40  Since it is a component of a number of bacterial surface antigens including Streptococcus 
pneumoniae,31,38 Streptococcus mitis41, Providencia alcalifaciens,42 Bacteroides fragilis43 and various 
serogroups of Shigella9, its synthesis has been more widely investigated. The most recent study provides 
a review of synthetic approaches to D-FucNAc4N (or AAT), and presents a particularly efficient synthesis 
of protected D-FucNAc4N (2) requiring 5 steps from allyl glycoside 1 in an overall yield of 46%, shown 
in Scheme 1.30 
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This was a novel strategy with a significant improvement in yield compared to the original reported 
synthesis of D-FucNAc4N by Medgyes et al.32   
 
1.5.2 Synthesis of L-AltNAcA 
The original synthesis of L-AltNAcA was also achieved by Medgyes et al.32 Starting with L-arabinose they 
followed a previously published nitromethane method44 to L-glucose in a 30% yield. Focus then shifted 
to the challenges in selective functional group conversions. 
 
 
1            2
  
Scheme 1: Synthesis of D-FucNAc4N (2) from Glycoside 1 
Scheme 2: Reagents and conditions (a) HCl, MeOH, 65°C, 24 h, 61% (b) C6H5CHO, ZnCl2, 62% (c) TsCl, NaOH, K2CO3, 
20°C, 1 h, 76% (d) NaOMe, MeOH, 65°C, 4 h, 77% (e) NaN3, NH4Cl, 2-methoxylethanol.H2O, reflux, 4 h, 66% (f) 
BnBr, NaH, DMF, 20°C, 73% (g) AcOH, H2O, 60°C (h) i: NaOCl, tetramethylpiperidine-1-oxyl, KBr, aq. NaHCO3, 20°C, 
2 h; ii: MeI, DMF, 20°C, 2 h, 62% (i) i: H2, 20% Pd(OH)2/C, MeOH, 20°C, 24 h; ii: Ac2O, 0°C, 1 h, 90% 
4                    5          6 
3 
30% 
9                         10                11 




Fischer glycosylation of L-glucose converted the hydroxyl group at C-1 to the methyl--L-glucoside 3. 
Acetal protection of O-4 and O-6 followed by tosylation at O-2 and O-3 gave ditosylate 5 which was 
transformed to the 2,3-epoxide 6. This key intermediate allowed for eventual inversion of configuration 
at both C-2 and C-3 via selective nucleophilic addition of azide at C-2, giving the desired configuration 
of the final product. Benzylation at O-3 and deprotection of O-4 and O-5 afforded  
L-altrose derivative 9. Selective oxidation of the primary hydroxyl group at C-6 gave the desired carboxyl 
group in 10. The final step included a catalytic reduction of the azide and acetylation to afford the final 
product, L-AltNAcA (11), as its methyl glycoside methyl ester.  
 
Two significant disadvantages in this route are clear: firstly, it started with monosaccharide L-arabinose 
and secondly, converting this to L-glucose was very low yielding (30%). This has prompted other efforts 
to develop a more efficient and cost effective route.  
 
Scheme 3: Reagents and conditions (a) i: AcCl, AllOH, 90°C, 16 h; ii: PhCH(OMe)2, CSA, CH3CN, 80°C, 2 h, 54%  
(b) i: MsCl, py, RT, 16 h; ii: KOH, THF/MeOH, 70°C, 16 h, 69% (c) NaN3, NH4Cl, DMF, 80°C, 48 h, 70% (d) BnBr, 
NaH, DMF, RT, 1 h, 91% (e) i: PPh3, H2O, THF, 60°C, 16 h; ii: (CCl3CO)2O, py, 0°C, 15 min, 91% (f) i: 80% aq. AcOH, 
60°C, 1 h; ii: TEMPO, BAIB, DCM/H2O, RT, 1 h; iii: BnBr, K2CO3, DMF, RT, 16 h, 74% (g) 
i: [Ir(COD)(PMePh2)2]+PF6-, H2, RT, 30 min; ii: I2 THF/H2O, RT, 30 min; iii: PTFACl, Cs2CO3, (CH3)2CO, RT, 2 h, 88%  
12                       13                     14 
15               16 




More recently, Pfister et al.30 proposed a new synthetic route to L-AltNAcA (Scheme 3) in a form in which 
it can be readily converted to both a glycosyl acceptor (18) and donor (19), for use in chain elongation 
towards the S. sonnei repeating unit. 
 
This route was largely based on the work of Medgyes et al.32 starting from L-glucose. Again starting with 
a Fischer-type glycosylation and regioselective protection of O-4 and O-6, the allyl -glycoside 13 was 
synthesised in a 3:1 excess over the -isomer. Following a similar sequence to invert C-2 and C-3, 
epoxide 14 was accessed via the 2,3-di-O-mesylate and trans-diaxial opening of 14 afforded  
2-azido altroside 15 preferentially (70%) over the trans-diequatorial product (6%). Protection of O-3 
and reduction at C-2 successfully produced the fully protected allyl -L-altrosamine (17). Deprotection 
and oxidation at C-6 lead to the desired glycosyl acceptor 18. 17 was also converted to imidate 19, 
through a deallylation and subsequent reaction of the formed hemiacetal with PTFACl, for use as a 
glycosyl donor. Overall the protected form of L-AltNAcA was synthesised in a 14% yield from L-glucose.30  
 
While this route does offer an effective synthesis of the desired target compound, the cost of the starting 
material (R1 429.75 per gram compared to D-glucose at R9.10 per gram) is a disadvantage.   
 
1.6 Synthesis of L-Sugars 
Since these are the only published syntheses of L-AltNAcA, the synthesis of other L-sugars from D-sugar 
starting materials was explored, in particular L-altrose which is a potent biological synthon and would 
be a valuable intermediate towards the desired L-altruronic acid.  Recent reviews of the synthesis of  
L-sugars was conducted by Zululeta et al.45 and Frihed et al.46 some of the key strategies are discussed 
below.  
1.6.1 Synthetic strategies towards L-altrose 
Two methods were identified which form L-altrose from D-sugar starting materials. 
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The first strategy shown in Scheme 4 effectively converts diacetone-D-glucose (20) to L-altrose (27) in 
its unprotected form in a 9% yield over 7 steps.47 The initial sequence involved an interesting 5,6- to 
3,5-acetal rearrangement and bromination at C-6 affording 6-bromoglucofuranoside 21. This was 
ideally set up for the elimination at C-6 followed by a stereoselective hydroboration coupled with an 
oxidative work-up to efficiently invert the configuration at C-5. The protected L-glucofuranoside 23 now 
differed from the desired L-altrose only at position 4. This inversion was also achieved via an 
elimination-oxidation sequence. Firstly, the migration of the acetal protecting group to its original 5,6 
position was achieved using 2,2-dimethyoxypropane and a catalytic amount of CSA leaving an OH at C-
3 which underwent elimination on treatment with DAST. The hydroboration of endocyclic olefin 25 was 
stereoselective and the oxidative work-up led to inversion at C-4 and restoration of the hydroxyl group 
at C-3. Acid hydrolysis of 26 removed the isopropylidene groups affording the desired target L-altrose 
(27).47 This route offered a viable option for the synthesis of L-AltNAcA from D-glucose. 
 
 
The second successful method started with a selectively protected form of D-glucose (28) to produce a 
similarly protected L-altrose (32) in 4 steps with an overall yield of 49% (Scheme 5).48 
20               21                 22 
23      24  
25     26     27 
Scheme 4: Reagents and conditions (a) PPh3, NBS, PhCH3, 110°C, 2 h, 75% (b) DBU, DMF, 110°C, 2 h, 84%  
(c) BH3.THF, THF, H2O2, NaOH, RT, 3 h, 90% (d) CSA, (CH3)2CO, 2,2-dimethoxypropane, RT, 42% (e) DAST, py, 




4-deoxypentenoside 29 was successfully prepared in a two-step sequence of oxidation followed by 
decarboxylative elimination. An epoxide which could be selectively opened to attain the desired 
configuration at both C-4 and C-5 was then synthesised. The epoxidation was achieved using DMDO with 
high facial selectivity to produce 30, with this high selectivity presumably due to the pyran system 
adopting a preferred 2H1 half-chair, where the two benzyloxy groups are pseudo-equatorial and the 
methoxy group pseudo-axial.48 This epoxide was found to undergo completely regioselective opening 
with a broad set of nucleophiles of which the most effective were Grignard reagents. Use of 
dimethylphenylsilyl methylenyl Grignard reagent provided silane 31 which was readily converted to 
the L-hexopyranoside (32) in which the hydroxyl at C-6 is reintroduced.  
 
1.6.2 Synthetic strategies towards general L-sugars 
Synthetic routes to more general L-sugars were then reviewed. Four basic methods were identified that 
showed potential adaptability towards preparation of L-AltNAcA. 
 
The first strategy (Scheme 6) has been published by two separate groups49,50 and used the readily 
available, 1,2-O-isopropylidene-6,3-D-glucoronolactone (33) as the starting material. The inversion of 
configuration at C-5 was accomplished by means of O-triflation at C-5 followed by SN2 inversion using 
the pivaloyl anion as a nucleophile to give 34. When the lactone was opened, this protecting group then 
Scheme 5: Reagents and conditions (a) i: TEMPO, KBr, n-Bu4NBr, NaOCl, NaHCO3, DCM/H2O, 0°C;  
ii: N,N-dimethylformamide dineopentyl acetal, PhCH3, 120°C, 70% (b) DMDO, (CH3)2CO, DCM, -55°C, 99%  
(c) PhMe2SiCH2MgCl, Et2O, RT, 86% (d) CH3CO3H, KBr, AcOH/NaOAc, 0°C to RT, 75% 
28        29     30 




migrated to O-3 to produce the 3-O-pivaloyl methyl ester 3549 which was subjected to hydrolysis of the 




However, transformation of 36 to an L-AltNAcA derivative would require a significant number of 
complex challenges, including selectively introducing the acetamido group at C-2 with retention of 
configuration, and inversion of configuration at C-4, and seemed an impractical alternative at this stage.  
Scheme 7: Reagents and conditions (a) BnO, Bu4NHSO3, NaOH (b) i) AcOH/H2O ii) NaIO4 (c) KCN, MgCl2, H2O, 
MeOH (d) TFA, H2O (e) CSA, 2-methoxypropene, THF (f) TsOH, H2O, THF (g) H2O2, K2CO3, dioxane, H2O (h) DMF, 
DMA(i) as seen above in Scheme 2 
Scheme 6: Reagents and conditions (a) i: Tf2O, pyridine; ii: NaOPiv, DMF (b) Et3N, MeOH, 0°C, overnight (c) TFA, 
RT, 3 h  
33     34  
35              36
   
20        37         38            39          40  
41                         42               43
  
44                     45  
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The second method (Scheme 7) started with the inexpensive dicaetone-D-glucose (20) which was 
protected at O-3 and then selectively deprotected at O-5 and O-6 before being reduced to the aldehyde 
38.51 Following this, a stereoselective cyanohydrin reaction successfully inverted the configuration at C-
5 giving the desired L-configuration. This was achieved in a 90% diastereomeric excess producing 39 
and a minor amount of 40. Carrying forward 39, treatment with TFA afforded the cyanated pyranoside 
41. Synthesis of the desired product 43 and a side product (42) occurred via a tris-acetal-protected 
intermediate. Removal of the acetal group at C-4 conveniently facilitated the conversion of 42 to alcohol 
43. The cyano group at C-5 was then converted to the methyl ester in 45 via amide 44.52 The 
disadvantage of this route is that it is long and many of the steps require difficult separations to get the 
desired product. While there have been more efficient versions of this route published recently by 
Gardiner et al53, unfortunately time did not permit exploration of this. 
 
Another approach, via an SN2 inversion at C-5, was successfully carried out by Orgueira et al.54, Ojeda et 
al50 and more recently Saito et. al.55 Once again starting with the readily available diacetone-D-glucose 
(20), an 8 step procedure was carried out to form 46 in an overall yield of 65%. It is reported to be 
scalable to 100g and requires little purification,54 factors which are definite benefits in a total synthesis. 
The inversion at C-5 is achieved on this furanose 46 through conversion of the hydroxyl in question to 
a better leaving group which can then be displaced by a nucleophile. In this case a levulinate anion was 
used which effectively formed the L-sugar 47. Treatment with hydrazine in acetic acid yielded the L-
sugar the structure is in the pyranose form (48) analogous to 36 in Scheme 6, and presenting similar 
challenges for the conversion to an L-AltNAcA derivative. 
Scheme 8: Reagents and conditions (a) i: NaH, BnBr, THF, Bu4NI; ii: AcOH, 40°C; iii: TBSCl, DMAP, DCM, py; iv: 
Ac2O, DMAP, py; v: HF/py, THF; vi: TEMPO, KBr, Bu4NBr, NaHCO3, NaOCl, DCM/H2O; vii: NaOH, MeOH; viii: MeI, 
KHCO3, DMF, 65% (b) TFA, 99% (c) i: TF2O, py, DCM; ii: NaOLev, DMF, 80°C, 82% (d) N2H4, AcOH, py, 91% 
20      46
  




The last method involved a very interesting sequence involving the initial ring-opening of D-xylose (49), 
shown in Scheme 9.56 49 was initially converted in 6 steps to di-thio acetal 50 which was immediately 
protected to form 51 with different protecting groups at O-2 and O-3.51 Removal of the isopropylidene 
acetal via acid hydrolysis was followed by a selective tritylation of the primary hydroxyl to produce 
alcohol 52. The hydroxyl group at C-4 was then alkylated to give a fully protected product which could 
be selectively modified at each carbon. The pentane chain of 53 was elongated in the key step of this 
synthesis via a sequence of deprotection, oxidation and subsequent diastereoselective cyanation to give 
55.56 Aldehyde 54 was a key intermediate as it allowed for the inversion of configuration at C-5 to 
produce L-idose after ring closure. Methyl ester 56 was synthesised using the Pinner reaction and was 
cyclised to produce pyranose 57 using NIS. 
 
This route has some very exciting chemistry however, the number of synthetic steps, the lack of 
crystalline intermediates thus leading to a lot of chromatography steps and the use of toxic reagents like 
cyanide, undesirable in terms of both human and environmental safety, make it unsuitable for the total 
synthesis of L-AltNAcA.  
 
Scheme 9: Reagents and conditions (a) Lubineau, 6 step reaction (b) AllBr, NaH, DMF (c) i) AcOH ii) TrCl, pyridine 
(d) NapBr, NaH, DMF (e) TFA, Et3SiH, CH2Cl2 (f) TMS-CN, MgBr2.OEt2, CH2Cl2 (g) i) AcCl, MeOH, toluene ii) H2O (h) 
NIS, CH2Cl51 
49                  50         51  
52           53     54  
55                56            57  
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1.6.3 Synthetic strategies in the inversion of configuration in sugars 
The inversion of a stereocentre in carbohydrates is of course not only confined to position 5. A common 
way to achieve this is by formation of a reactive triflate at the appropriate hydroxyl group followed by 
an SN2 inversion by a nucleophile. This was described above for molecules in the furanose form but has 
also been successful on pyranose rings at a number of difference positions.36,57,58 Other options include 
the Mitsunobu inversion, reactions proceeding via oxidations of free hydroxyl groups followed by 
stereoselective reduction, and eliminations followed by stereoselective oxidations, similar to the 
hydroboration reactions described above.  
 
The foregoing summary provides some insight into the challenges and difficulties of synthesising  
L-sugars from D-sugars and justified the investigation of a new, efficient synthetic route to L-AltNAcA 
starting from readily available materials. 
 
1.7 Proposed Alternative Synthetic Routes to L-AltNAcA 
Starting from the most abundant monosaccharide, D-glucose, the key challenges in the synthesis of  
L-AltNAcA are highlighted in Scheme 10. Two inversions of configuration, at C-4 and C-5, would be 
required in order to prepare L-altrose. Following this, oxidation at C-6 would provide the desired  
L-altruronic acid, and finally changing the functionality at C-2 to an acetamido group with retention of 
configuration to give the target compound, L-AltNAcA. With these challenges in mind and based on the 
reviewed literature, two synthetic routes were proposed for the synthesis of L-AltNAcA, the first starting 
from diacetone-D-glucose and the second from N-acetyl-D-glucosamine. 




1.7.1 Proposed route starting from diacetone-D-glucose 
The most effective synthesis reported in the literature that converted D-glucose to L-altrose was 
described in Scheme 4.47  This route was adapted for the synthesis of biologically important L-hexoses 
by Lee et al.59 The potential of this modified route to be adapted to the synthesis of L-AltNAcA was 
recognised and is described in Scheme 11. This route also presented the opportunity to explore 
interesting and novel chemistry.  
 
 
Following the original route carried out by Hung et al.47 (Scheme 4) the sequence would start with a 
reaction of di-acetal 20 with PPh3 and NBS to form 21, in which bromination at C-6 would be achieved 
with rearrangement of the 5,6-acetal to the 3,5-acetal. The base induced elimination forming 22 would 
be carried out using either NaH or DBU. The inversion at C-5 to give L-idose derivative 23 would be 
Scheme 11: Reagents and conditions for proposed synthetic route from 20 to L-AltNAcA (a) 3 step route 
described in Scheme 4 (b) HCl, EtOH (c) i: TMSCl, Et3N, DCM; ii: PhCHO, TMSOTf, Et3SiH, DCM (d) i: BzCl, DCM, py; 
ii: Tf2O, py (e) NaNO2, H2O (f) TMSCl, py (g) NaOMe, MeOH (h) i: oxidation; ii: oximation (i) i: LAH; ii: Ac2O  
(j) TFA, Ac2O 
20                  23    58 
59                 60             61 
62                63           64 
65                66           67 
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carried out by means of the stereoselective hydroboration-oxidation process with hydrolysis then 
providing 1,6-anhydro-L-idose. A modification of published procedures59 would be followed to achieve 
the desired selective inversion at C-4 resulting in the L-altrose configuration seen in 61. This route made 
use of the 1,6-anhydro bicyclic system seen in compound 58 which was then able to be selectively 
modified at positions, 2, 3 and 4. This method offered more selectivity than the original route for the 
functional group interchange that would need to be performed at C-2. The selective benzylation of O-3 
would be carried out first via a tris-trimethylsilyl intermediate. The subtly different electronic 
environments at C-2 and C-4 would then be exploited to achieve the inversion via the triflate (60) to 
form L-altrose 61. At this point the route would be adapted for the purpose of synthesising  
L-AltNAcA where the functionality at C-2 would be converted to an NHAc group and O-6 oxidised to give 
the desired selectively protected L-altrouronic acid 67. 
 
1.7.2 Proposed alternative route starting from N-acetyl-D-glucosamine 
The obvious benefit of starting from N-acetyl-D-glucosamine (68) is that the desired NHAc is already in 
place at C-2. An interesting rearrangement and derivatization of compound 68 was reported by Mack et 
al.60 (Scheme 12) in which the fused furano-oxazoline (69) is formed, while simultaneously protecting 
O-5 and O-6 as an isopropylidene acetal.  
 
Compound 69 has a very similar structure to 20 and it was thus proposed that the sequence in Scheme 
11 could potentially be carried out to synthesise compound 71 which could be further modified to form 
L-AltNAcA. Failing this, the sequence forming 72 would be attempted which takes advantage of the 
selectively unprotected O-3 and different reactivity of the oxazoline and isopropylidene groups. From 
16 
 
72, the key inversion at C-5 could be achieved following a similar method as Orgueira54 and Saito55 as 
described in Section 1.6.2. 
 
 
The aim of this project was therefore to contribute to the preparation of a glycoconjugate vaccine 
candidate for S. sonnei by synthesising a suitable derivative of the acidic sugar, L-AltNAcA, found in the 
repeating unit of S. sonnei. The proposed synthetic routes as discussed above were the focus of this 
project. In relation to the first route, specific emphasis would be placed on the investigation of 
alternative methods for discriminating between the three hydroxyl groups in 1,6-anhydro--L-
idopyranose. Achievement of such selectivity would allow for the selective inversion of the 
configuration at C-4 and converting the hydroxyl at C-2 to the desired acetamido group. The emphasis 
in the second route, which already has the 2-acetamido group in place, would be placed on optimizing 
the chemistry required for achieving the inversion of configuration at C-5. All compounds synthesised 
en route to the target compound L-AltNAcA would be fully characterised by 1D 1H and 13C NMR 




69         70    71 
68 
Scheme 12: Overview of the proposed routes starting from N-acetyl-D-glucosamine (a) BF3.Et2O, (CH3)2CO  
(b) PPh3, NBS, CH3CN (c) as detailed in Scheme 11 (d) i: inversion of C-5; ii: Deprotection of O-6 (e) hydrolysis 




Synthetic Route 1: 
Since L-sugars are rare and proportionately expensive, a monosaccharide in the D–configuration was 
selected as the starting material. Therefore, it was essential to arrange the carbohydrate structure to 
allow selective manipulation of C-5 to achieve the key inversion of configuration at that centre.  
D-Glucose is the cheapest and most readily available monosaccharide however is difficult to selectively 
protect, particularly at positions 1 through 5 where the hydroxyl groups are in similar chemical 
environments. Diacetone-D-glucose which is already selectively protected was thus selected 
preferentially.  Following literature procedures,1–3 the key intermediate 1,6-anhydro-β-L-idopyranose 
was successfully synthesised via the proposed four step synthesis. A study of chemo-and regioselectivity 
was subsequently carried out in order to derivatise 1,6-anhydro-β-L-idopyranose into the desired L-
AtlNAcA.  
  
2.1 Preparation of 1,6-Anhydro-β-L-idopyranose 
Following the procedure of Lee et al.59 this four step sequence successfully achieved the inversion of 
configuration at C-5 and a further transformation to triol 58 which is set up for selective protections 
and modifications towards L-AltNAcA.  
Scheme 13: Reagents and conditions (a) NBS, PPH3, CH3CN, MS, 80°C, 20 h, 70% (b) NaH, DMF, 0 - 20°C, 16 h, 95% 
(c) i: BH3.THF, THF, RT, 3.5 h; ii: H2O2, NaOH, 0°C, 0.5 h, 71% (d) 0.2M HCl in EtOH, 95°C, 17 h, 80% 
20               21 
     
   22         23              58 
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The first step in this sequence involved an interesting rearrangement of the isopropylidene group 
together with selective bromination at C-6 in order to set up the possibility of a selective elimination at 
C-5, C-6, while leaving all the other functional groups protected. Treatment of diacetone-D-glucose with 
NBS and PPh3 in acetonitrile gave the desired product (21) in low yield (<40%) after the recommended 
aqueous workup. This was eventually improved to 70% on a three gram scale through rigorous 
exclusion of water by using 4 Å molecular sieves in the reaction, extending the reaction time and 
avoiding the aqueous workup. NMR analysis confirmed the formation of the desired product (21) with 
all data corresponding to that in the literature.61 
  
The diagnostic peaks shifts are seen in Figure 3, which shows in particular the significant upfield shifts 
of signals for H-5 and H-6 due to the electron donating bromine. H-5 couples to the two H-6 protons and 
H-4 which is evident from its signal at 3.74 ppm, which changed from a multiplet to an apparent triplet 
of doublets due to the increased rigidity of the product. This resulted in more distinct splitting patterns 
in the H-3, H-4 and H-6 signals and the disappearance of the doublet at 2.60 ppm for the hydroxyl at C-
3. 
Figure 3: Diagnostic shifts in 1H NMR signals from compound 20 to 21 
 H-4    H-3       H-5          H-6 
H-3  H-5    H-6     H-4                 3-OH
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The proposed mechanism for this reaction is shown in Figure 4. It is suggested by Hodosi et al.61 that, 
based on their NMR experiment results, an initial reaction occurs between NBS and PPh3 forming a 
phosphonium salt.  The least hindered oxygen in 20 then forms an intermediate phosphonium salt, A, 
followed by opening of the dioxolane ring to form oxocarbenium intermediate, B. This rearranges to the 
3,5-ketal while at the same time the bromide ion attacks at C-6 to release PPh3O to give the  
6-deoxy-6-bromo product 21.  
 
Figure 4: Proposed mechanism for rearrangement and bromination of diacetone-D-glucose 
 
The next step required an elimination to prepare the exo-olefin required for the anticipated 
stereoselective hydroboration reaction. This was achieved using NaH in DMF62 affording the desired 
enol ether 22 in 95% yield after purification by column chromatography.  
 
Confirmation was seen in the NMR spectra which agreed with reported data.59 Figure 5 shows, in 
particular, the signals for two H-6 protons which appear as two doublets at 4.76 and 4.69 ppm, 
considerably further downfield from their position in the spectrum of 21, together with the expected 







The elimination of HBr presumably occurred via an E2 type mechanism shown in Figure 6 . 
 
The next reaction addressed the key challenge in this synthetic route, the inversion of the stereocentre 
at C-5 to give the desired L-configuration for the target molecule. This was achieved by stereoselective 
hydroboration and subsequent oxidation to give 23 in a 71% yield. The product was confirmed as a 
single diastereomer by NMR spectroscopy with data corresponding to that in the literature.59 The most 
diagnostic feature in this spectrum (Figure 7) was the appearance of a multiplet for H-5 at 4.11 ppm 
significantly downfield compared to H-5 in the 6-bromo product. The two signals for H-6 have 
H-6a    H-6b
  
Figure 5: 1H NMR spectrum of enol ether 22 





correspondingly shifted further upfield, again confirming the presence of a hydroxyl at that position. 
The signal for H-4 appears as a triplet resonating at 4.01 ppm but is in fact an overlapping doublet of 
doublets with two small couplings of 2.2 Hz. The signal for H-4 in compound 21 is a doublet of doublets 
with one large coupling (7.2 Hz) and one smaller coupling (3.9 Hz) corresponding to the close-to anti 
peri-planar relationship between H-4 and H-5. The change observed in 23 corresponds to a much 
smaller dihedral angle between H5-C5-C4-H4, close to 0°, which is consistent with the inversion of 
configuration at C-5. 
 
The observed stereoselectivity in the addition of borane can be explained by the steric congestion in 
compound 23 (Figure 8). The β-face of 
transition state C has the C4–O4 in a pseudo-
axial orientation eclipsing the incoming 
borane, which discourages this approach to 
give alkyl borane C’ (or its tri-alkyl analogue) 
as an intermediate, which is itself high in 
energy due to diaxial repulsion between C-6 
and the isopropylidene CH3. In contrast, 












Figure 7: 1NMR spectrum of compound 23 
H-2            H-3      H-5   H-4         H-6a      H-6b 
Figure 8: Facial selectivity in hydroboration step 
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This forms intermediate D’ which is more stable than its counterpart C’ since the bulky borane group is 
equatorially-oriented.59 Therefore pathway D is both kinetically and thermodynamically favoured.  
 
The reaction thus starts with the syn addition of borane to the α-face of the double bond (transition state 
D in Figure 8) with possible formation of the trialkyl borane, and then subsequent oxidation to give 
1,2:3,5-di-O-isopropylidene--L-idofuranoside (23) in an overall anti-Markovnikov addition of H2O.  
 
After successfully inverting the stereocentre at C-5 via the stereoselective hydroboration of the exo-
cyclic double bond, the final step in this initial sequence involved preparation of 1,6-anhydro-L-idose 
(58) as a potentially versatile synthetic intermediate. This involved refluxing idofuranoside 23 in 
acidified ethanol, effectively removing the isopropylidene groups and catalysing the rearrangement to 
form the 1,6-anhydro pyranose form as shown in Figure 10. A single product was isolated after column 
chromatography and was confirmed by NMR analysis to be the desired 1,6-anhydro--L-idopyranose in 
an 80% yield which agreed with reported literature data.59 
 
4-OH             3-OH            2-OH 
Figure 9: 1H NMR spectrum of compound 58 
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Figure 10: Proposed mechanism for deprotection and anhydro ring formation 
Due to the increased polarity of this compound the NMR were recorded in (CD3)2CO which facilitates 
the appearance of OH peaks as clear doublets (Figure 9) in addition to the signals for 7 protons of the 
carbohydrate skeleton. These were assigned with reference to literature data59. The disappearance of 




The reaction presumably proceeds as shown in Figure 10, with initial removal of the isopropylidene 
protecting groups to give the furanose intermediate (E) which is in equilibrium with the open chain 
aldehyde, F. This is in turn in equilibrium with the 6-membered pyranose ring (G) which under acid 
hydrolysis loses the anomeric hydroxyl to form an oxocarbenium ion which is trapped by the 6-OH to 
form 1,6-anhydropyranose, 58. 
 
2.2 Attempted Selective Protections of 1,6-Anhydro-β-L-idopyranose 
With this key intermediate in hand an investigation was initiated into the possibility of differentiating 
between the three free hydroxyl groups through selective protection/deprotection sequences. The 
ultimate aim, as shown in Figure 2, was to achieve the inversion of configuration at C-4 and functional 
group conversion at C-2, while O-6 remained protected to allow for oxidation at C-6 at a later stage.  
 
A review of the literature showed that a number of research groups had been successful in derivatising 




















this study was to follow the approach of Hung’s group at the Academia Sinica in Taiwan45,59, who had 
successfully carried out a series of regioselective protections which enabled further selectivity in the 




The key features that were of interest for application in the synthesis of L-AltNAcA were the protections 
using benzyl and benzoyl groups sequentially in 59 and 60 and selective inversion via a triflate 
intermediate to form 61 (Scheme 14). Other research suggested that stannylene-mediated chemistry 
might achieve selectivities in benzylations63 and benzoylations64. In addition, similar selectivity has been 
observed in acetylation reactions65, modified Mitsunobu reactions66,67 and also in selective deprotection 
of fully benzylated 1,6-anhydro D-sugars68. The aforementioned literature provided the rationale for the 
studies that were done on the selectivity in 1,6-anhydro-β-L-idopyranose. 
 
2.2.1 Attempted inversion of configuration at C-4 following Hung’s route59 
In the first instance, selective benzylation was attempted via the TMS ethers as reported by Hung et al.59 
This approach is in line with that proposed by Hung et al.59 who argued that the selectivity arose from 
differences in steric strain in the molecule imposed by the substitutions at the different hydroxyl groups.  
Scheme 14: Work published by Hung et. al.45,59 Reagent and conditions (a) 2M HCl, EtOH (b) i: TMSCl, Et3N; ii: 
PhCHO, TMSOTf, Et3SiH (c) BzCl, DCM, py, Tf2O (d) NaNO2 (e) Tf2O, py, BzCl (f) NaNO2 (g) Tf2O, py (h) NaNO2 (i) 
BzCl, py (j) Ac2O, Sc(OTf)3 
80             81 
78             79 
75             76 
60             61 







The results are shown in Scheme 15. The tris-trimethylsilyl ether was successfully prepared in an 84% 
yield when 58 was reacted with excess TMSCl in DCM under basic conditions. The structure was 
confirmed by NMR analysis which correlated with that in the literature.59 The three new 9 proton 
singlets at 0.14, 0.14 and 0.17 ppm confirmed the presence of the TMS groups.  Selective benzylation 
was then attempted with encouraging results. Initial attempts led to the 3-O-benzyl compound 59 as a 
major product with the two dibenzyl ethers 83 and 84 as minor products (Scheme 15). However, the 
yield of the desired compound 59 was increased to 90% on a 0.2 g scale and 60% on 1.0 g scale by 
maintaining the reaction temperature at -78°C during and after addition of catalytic amount of TMSOTf. 
The reaction mixture was only allowed to warm to room temperature after addition of Et3SiH in order 
to effect the reduction of the TMS-acetal to form the desired benzyl group at O-3. The proposed 
mechanism for this reaction sequence is outlined in Figure 11. The remaining TMS groups at positions 
2 and 4 were then cleaved using TBAF.  
 
Scheme 15: Reagents and conditions (a) TMSCl, Et3N, DCM, RT, 4 h, 84% (b) i: TMSOTf, PhCHO, MS, Et3SiH, DCM, -
78°C, 1 h; ii: TBAF, THF, RT, 1 h, 43% major product 59, 20% 83 and 7% 84 
58            82    59          83                 84
     





This structure 59 was confirmed by the appearance of two key signals in the 1H NMR spectrum (Figure 
12), confirming the presence of a single benzyl group. These were a multiplet in the aromatic region 
which integrated for 5 protons, and an AB quartet resonating at 4.85 ppm which is characteristic of the 
benzylic CH2. The latter splitting pattern, from a signal that would ordinarily be a singlet, results from 
each proton being in a slightly different chemical environment due to the rigidity of the molecule. In 
addition there were two doublets at 4.67 and 4.27 ppm corresponding to the free hydroxyl groups at C-
4 and -2 respectively, with assignments confirmed by the COSY spectrum. These data correlated with 
that in the literature.59 
 
 
After successfully achieving selectivity in the benzylation of O-3, the inversion of configuration at C-4 
was investigated. This required initial selective protection of the 2-OH, preferably using a different 
group to that at O-3. To this end an adaptation of the route described by Lee et al.59 was attempted as 
shown in Scheme 16. The selective benzoylation at O-2 was first carried out independently to test the 
viability of this route with the intention of then attempting a sequential one-pot benzoylation and 
triflation. To this end, diol 58 was treated with BzCl and pyridine at low temperature. The reaction did 
H-2 













not go to completion and gave monobenzoate 81 in 20% yield together with recovered starting material 
(28%).  
 
The structure of 81 was confirmed by 1H NMR (Figure 13). Three additional signals in the aromatic 
region integrating for 5 protons in total indicated the presence of the benzoyl group. Its location was 
confirmed by the downfield shift in the signal for H-2 which now resonated at 4.92 ppm while the signal 
for H-4 remained further upfield. Although the yield for this reaction was low, the proof of concept was 
demonstrated through the fact that none of the 4-O-benzoyl sugar formed. The one-pot benzoylation at 




BzCl was added to a solution of 59 in DCM and pyridine and stirred for 4 h at 0°C. Tf2O was then added 
to the reaction mixture and this was stirred at room temperature for 1 h after which it was quenched 
with MeOH. A product was isolated and analysed by NMR which showed that, unfortunately, two 
products had formed. This was most evident in the 1H spectrum in Figure 14 where a doubling of signals 
in a 1:2 ratio could be seen. Since the products were present in different amounts, it was possible to 
Scheme 16: Reagents and conditions (a) BzCl, DCM, py, 0°C, 4 h, 20% (b) Tf2O, py, RT, 1 h, 59% (d) NaOBz, DMF, 
0→20→90°C 
Bz-H      Bn-H  
Figure 13: 1H Spectrum of compound 81 
59               81         60                 85 
    
             H-1                      H-2      H-4 
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determine their structures through careful analysis of the 2D spectra of this mixture and comparison to 
reported literature.59 
 
The major product was identified as 60 which correlated with literature.59 The diagnostic peaks 
confirming this are highlighted in Figure 14. The signal for H-2 resonates at 5.13 ppm, a similar chemical 
shift to that in 59 while the signal for H-4 has shifted downfield, consistent with triflation at O-4. 
Coupling between the signal for H-2 and a carbonyl signal in the HMBC proves that the benzoyl group is 
indeed at O-2. Final confirmation of the presence of the triflate was found in the 13C spectrum. Although 
it is proton decoupled, the presence of the fluorine is evident from the appearance of a quartet for CF3, 
due to C-F coupling. 
 
Even though these results show that the reaction was not highly selective compared to literature which 
reported an 88% yield of 60, the desired compound had formed and was the major product. However, 





H-2    
H-4 
Figure 14: NMR Spectra for mixture of compound 60 and minor product (A) 1H (B) 13C (C) COSY (D) HSQC 
 
1, 2  
2, 3  
4, 3  
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presence of a good leaving group at C-4 would allow for an SN2 inversion, leaving a protected hydroxyl 
group at this position. 
 
When triflate 60 was treated with NaOBz in DMF at 0°C or at room temperature there was little reaction 
progress as judged by TLC. However, when the reaction mixture was heated to 90°C all of the starting 
material appeared to be consumed after 3 h. After workup and purification by column chromatography 
two compounds were isolated, the less polar of which was recovered smarting material (34%) while the 
more polar compound was shown by NMR to be a mixture of compounds. Attempts to separate these by 
preparative TLC were not successful and no evidence emerged to support the formation of the desired 
product. With this reaction being unsuccessful, the previous step only moderately selective and the O-2 
benzoylation low yielding, it was decided that this direct route to the selective C-4 inversion was not 
feasible.  
 
Returning to the 1,6-anhydro-3-O-benzyl--L-idopyranose moiety, a modified Mitsunobu reaction66,67 
was attempted in the hope that one equivalent of reagents would achieve a selective inversion at either 
C-2 or C-4. DIAD was added to a mixture of 59, PPh3 and PhCOOH in anhydrous THF which had been 
cooled to 0°C. There was no reaction progress 0°C or at room temperature as judged by TLC. Even after 
increasing the temperature to 60°C no reaction occurred and only starting material was recovered from 
the reaction mixture.  
 
2.2.2 Investigation of reactivity differences between hydroxyl groups in triol 58 
After failing to replicate the selectivity achieved by Hung et al.45,59 an investigation into the possible 
differences in reactivity of the hydroxyl groups in triol 58 was conducted by doing reactions under 
standard, uncatalysed conditions as low temperatures. Although not all of Hung’s work could be 
repeated, the selective benzylation at O-3 was successful and thus compound 59 was investigated first. 
Failing that, further investigations into the differences in reactivity of 2-, 3- and 4-OH in 58 would be 




It was hypothesized59 that the inductive effects of the two oxygens at C-1 increased the acidity of 2-OH 
therefore making it more reactive to electrophiles than 4-OH under basic conditions. The first attempt 
at a selective protection was to use PMB as the electrophile since it can be selectively removed in the 
presence of the benzyl at O-3. 59 was treated with one equivalent of PMBCl and NaH in DMF at 0°C. After 
4 h at this temperature TLC showed little to no progress so the reaction mixture was warmed to room 
temperature. After 12 h it was clear that no more starting material was being consumed so the reaction 
was quenched with MeOH and purified by column chromatography. Two products were recovered 
together with starting material (27%). The less polar product was identified easily by NMR as the di-
PMB ether 86 (50.1%). A single anomeric signal resonated at 5.35 ppm, additional aromatic peaks 
integrating for 8 protons appeared between 7.42 and 7.19 ppm, two additional CH2 peaks had appeared 
as well as two singlets integrating for 3 protons each at 3.78 ppm. These data were consistent with the 
presence of two PMB groups thus confirming that compound 86 had formed.  
 
The more polar compound migrated on TLC as a single product, recovered in 19% yield. However, two 
anomeric signals were seen in the 1H NMR spectrum indicating that a 1:1 mixture of two distinct 
products with the same Rf had formed. Although these were inseparable, information on their structures 
was obtained by careful analysis of the NMR spectra of the mixture. The aromatic signals between 7.42 
and 6.80 ppm integrated for 18 protons in total which suggested that the two compounds each had one 
benzyl and one PMB group and suggesting the presence of a mixture of the two alcohols 87 and 88. 
 
Four CH2 signals were present which agreed with the proposed structures. The six-proton doublet 
resonating at 3.78 ppm, suggesting two overlapping methoxyl singlets, and signals in the ring proton 
region integrating for 14 protons provided further strong evidence for the formation of the two products 
87 and 88. Although as noted earlier, it proved impossible to separate and fully 
 characterize each product.  
 
Scheme 17: Reagents, conditions and products for the PMB reaction (a) PMBCl, NaH, DMF, 0°C, 4 h, RT, 12 h  
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The next attempt at selectively protecting O-2 was to 
use TMS which is a less bulky group than PMB creating 
less steric strain in the product and potentially 
increasing the yield.  A smaller group could react faster 
allowing for reduced reaction time which might also improve selectivity. 59 was treated with Et3N and 
TMSCl in DCM at 0°C. However, no reaction took place even after it was warmed to room temperature 
and the reaction time increased to 48 h. These results therefore demonstrate that even at low 
temperature there is no significant difference in the reactivity of the 2-OH and 4-OH.   
 
2.2.3 Tin mediated protections of 1,6-anhydro--L-idopyranose 
It was then hypothesised that if O-2 was selectively protected by a benzyl or benzoyl group first, the 
subsequent protection of O-3 would be easier as it is under less steric strain than O-2. Although there 
has been reported success in regioselective benzoylations simply through the use of BzCl in pyridine69, 
previous attempts on 58 suggested that this would not give adequate selectivity. High regioselectivity 
had been described when using Bu2SnO as a catalyst in benzylations63 (Scheme 19) and benzoylations64. 
Since there was already some observed selectivity at O-2, the tin catalyst could potentially enhance that 
feature. The formation of stannylene complexes (Scheme 20) with compound 58 shows the potential 
products from a tin mediated reaction with either benzyl or benzoyl protecting group.  
 
Two experiments were carried out according to the reaction conditions detailed in the aforementioned 
literature and are summarized in Table 1. In both reactions Bu2SnO was added to 58 and refluxed for at 
least 30 mins before adding the other reagents, in order to allow the stannylene complexes to form and 
possibly influence the regioselectivity. In the benzoylation reaction three compounds were collected 
after purification by column chromatography. Two of these were in fact mixtures of two products as 
Scheme 18: Reagents and conditions for 
attempted silylation of 59 (a) TMSCl, Et3N, DCM, 
RT, 48 h 
     59    89 
 
    
Scheme 19: Reaction reported by Zhou et. al.63 showing regioselectivity through tin mediated benzylation (a) 1.1 
equiv Bu2SnO, 0.5 equiv TBAB, 1.2 equiv BnBr, 100°C, 8 h, 83% 
     90         91 
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shown in Table 1. The 2-O-benzoate 92 and 4-O-benzoate 93 had a combined yield of 56% and were in 
a 1:4 ratio determined by NMR. Di-O-benzoylated products 94 and 95 were also collected as a mixture 










In contrast, in the stannylene-mediated benzylation reaction, the three monobenzylated compounds 59 
(30%), 97 (22%) and 98 (22%) were formed in the second reaction in approximately equal proportions, 
with the 3-O-benzyl ether 59 slightly dominating. The variety of products formed in these reactions was 
most likely the result of stannylene complexes forming both intra- and intermolecularly.64  
 
The structures of the products formed in these reactions were determined from NMR experiments using 
a combination 1H, 13C, COSY, HSQC and HMBC. The COSY spectrum (Figure 15) clearly shows the 1:4 
mixture of 92 and 93. Although the aromatic region showed overlapping signals, the signals for the 
independent ring systems of the two compounds were sufficiently resolved to allow full assignment of 
both structures with the assistance of this spectrum. 
Scheme 20: Stannylene complexes formed with 66 and their potential products 



































































































































































































































































































































   
   
   
   










   
   
   
















   
   
   



















The position of the signal for H-2 in 92 indicates that it is significantly deshielded compared to that for 
93 supporting the proposed structures. The same is true for H-4 for 92 which is shifted further 
downfield than in compound 92. The HMBC spectrum provided further confirmation of the positions of 
the benzoates in the two compounds. As highlighted in Figure 16, there are very distinct cross peaks 
between the benzoate carbonyl signals and H-2 of 92 and H-4 of 93 respectively, proving that the 
benzoyl groups are indeed at those positions. 
 
The structures of the two di-benzoylated compounds 94 and 99 were determined in a similar fashion 
as they were also recovered as an inseparable mixture after chromatography. It was again possible to 
estimate from 1H NMR that 94 and 95 were present in a 2:3 ratio, on the basis of analysis of the two 




































Figure 15: COSY Spectrum for compounds 92 and 93, with two anomeric signals highlighted, as well as 
correlations to the respective H-2’s and H-4’s, which differ dramatically in chemical shift due to the presence or 
absence of the benzoate ester 
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is significantly deshielded compared to that for 95 suggesting that 94 has a benzoyl group at O-2 but 95 
does not. The same is true for H-3 for 95 which is shifted further downfield than in compound 94.  The 
signal for H-4 in each compound was deshielded compared to the starting material 58. In addition, the 
increased integral for the aromatic peaks indicated that there were two phenyl groups present for each 
compound confirming the proposed structures.  
 
The tri-benzoylated product 96 was the least polar compound from this reaction and was isolated and 
characterised easily since it was clear from its 1H NMR spectrum (Figure 17) that only one product was 
present. The signals for H-2, H-3 and H-4 were all shifted downfield from their positions in the spectrum 
of the starting material 58. The aromatic region showed signals correlating to 15 protons and the lack 
of hydroxyl signals confirmed that this was indeed the fully protected carbohydrate.  
 
The range of products formed was most likely due to the wide number of stannylene complexes that 
could form between 58 and Bu2SnO which can bridge two compounds forming a type of dimer. This 
Figure 16: HMBC spectrum for compounds 92 and 93 
C=O, 2 for 92 
  




opens up a variety of selectivities ultimately leading to the complex mixtures observed. In addition to 
this, it has been reported that acyl groups such as benzoyl can undergo migration to adjacent hydroxyls 
in the presence of tin oxide mediators.64 Unfortunately, while this outcome does show selectivity it is 
not useful synthetically since it was not able to be isolated as a pure compound. 
 
The results from the tin mediated benzylation were less encouraging. Although three monoprotected 
products were formed there was no clear selectivity. As in the case of the benzoylation experiment, the 
least polar compound was isolated as a single pure compound. There was a single anomeric peak in the 
1H NMR spectrum, which was identical to that of the previously synthesised benzyl compound, and the 
structure therefore assigned as 1,6-anhydro-3-O-benzyl--L-idopyranose, 59.  
 
The two mono-benzyl ethers 97 and 98 were recovered as an inseparable mixture, as became apparent 
from their NMR analysis. The spectrum showed two signals for anomeric protons and twinning of all the 
other signals between 3.2 and 4.9 ppm. From the integrals it was evident that there were two 
compounds present in a 1:1 ratio, and this, together with the overlap of some signals, made resolution 
of the respective spin systems difficult. However, through careful examination of the COSY spectrum, 
(Figure 18), the two systems could be resolved and it was evident that two mono-protected compounds 
were present.  
 
Figure 17: 1H NMR spectrum of compound 96 
H-3   H-1    H-2     H-4 
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Evidence for the presence of two benzyl groups came from the presence of two overlapping AB quartets 
integrating for four protons, and the presence of 10 protons in the aromatic region. The location of these 
protecting groups was determined through cross peaks in the HMBC spectrum between the benzylic 
CH2 signals and C-2 of 98 and C-4 of 97. In addition, the presence of signals correlating to hydroxyl 
groups at the respective positions in the two products confirmed the proposed structures for the two 




After reviewing the results from these attempted regioselective protections and inversion, it was 
concluded that little progress was being made towards the total synthesis of L-AltNAcA. The steric and 
stereoelectronic environments in 1,6-anhydro-β-L-idopyranose were simply not sufficiently distinct to 
achieve good selectivity between C-2, C-3 and C-4. The second proposed route starting from readily 
available N-acetyl-D-glucosamine was thus investigated as proposed in Chapter 1.  
Figure 18: COSY spectrum of compounds 97 and 98, with two anomeric signals highlighted, as well as the 2- and 



















Synthetic Route 2: 
In light of the failure to efficiently discriminate between the 2-, 3- and 4-OH groups in triol 58, the focus 
was shifted to the second proposed route (Scheme 12) starting from readily available N-acetyl-D-
glucosamine, which already has the desired acetamido group at C-2 in the correct configuration.  
3.1 Preparation of Oxazoline 
The first step in this alternative route involved the formation of the cis-fused furano-oxazoline 69.60 This 
reaction traps the carbohydrate in the furanose form while simultaneously protecting all but the 3-
hydroxyl group (Scheme 21).  
 
This is achieved by treating 68 with BF3.Et2O and refluxing in acetone. The reaction proceeds via the 
mechanism outlined in Figure 19. The probable sequence is that after the sugar equilibrated to the open-
chain form H, the 5,6-diol is trapped by the activated acetone to form the acetal, followed by formation 
of the furanose form and finally formation of the 1,2-oxazoline via acid-catalysed formation of an 
intermediate oxocarbenium ion. An excess of lewis acid BF3.Et2O was therefore required as it was 
involved in the formation of both the isopropylidene and oxazoline rings. Although furanose is 
thermodynamically less stable than the 6 membered pyranose70, its formation is encouraged by two 
factors. Firstly, the formation of the isopropylidene ring in which O-5 is constrained and is therefore 
unable to reform the pyranose ring. And secondly, in the fused bicyclic system, the oxazoline ring exists 
Scheme 21: Reagents and conditions (a) BF3.Et2O, (CH3)2C=O, MS, RT, 3.5h, Et3N, 90% 60 
68      69 
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preferentially in the cis configuration which would not be possible in the pyranose from with the 
nitrogen and anomeric oxygen in equatorial and axial positions respectively.70 
 
Figure 19: Proposed mechanism for the formation of oxazoline 69 
68           H     
          B 
I       69 
Figure 20: COSY spectrum of compound 69 
1, 2  
2, CH3 




The NMR analysis of 69 was in agreement with reported literature.60,71 A doublet integrating for 3 
protons at 2.00 ppm in the 1H spectrum with a cross peak to H-2 in the COSY spectrum (Figure 20) 
confirmed the presence of the methyl group on the oxazoline ring. This appears as a doublet due to the 
long range coupling to H-2 (Figure 20) which is as a result of the angles introduced by the bicyclic ring 
system bringing the protons close enough in space to observe long range coupling. Two other methyl 
peaks at 1.39 and 1.33 ppm confirmed the presence of the isoprolylidene ring.  
 
3.2 Attempted Synthesis of 70 
With 69 in hand, the possibility of carrying out the PPh3-mediated bromination and rearrangement of 
the isopropylidene acetal to form 70 was investigated. Compound 70 could then be further modified to 
99 (Scheme 22) following the same sequence used to form 58.  
This reaction was first attempted using the optimised reaction conditions from the diacetone-D-glucose 
(20) reaction. TLC indicated that the starting material was being consumed but no product was apparent 
and NMR of the crude reaction products gave no evidence of the expected structures. The reaction was 
attempted in a number of different solvents while varying the temperature and reagent equivalents 
(Table 2, Appendix), none of which were successful. Although this reaction was not investigated further, 
it seems likely that the nitrogen in the oxazoline ring co-ordinates to the phosphonium species, 
triggering the opening of the ring and further degradation. 
  
69          70     71  
Scheme 22: Envisioned synthetic route from 69 to 99 analogous to that in Chapter 2 
99          100                 101  
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3.3 Selective Protection and Rearrangement of Oxazoline 69 
Focus was thus shifted to the alternative proposed route (Scheme 12/23) elaborated below. This 
reaction sequence started with the protection of O-3 followed by selective opening of the oxazoline and 




The benzylation of O-3 was successfully achieved by treating 69 with BnBr and NaH in DMF to produce 
102 in a 61% yield after purification.36,71 NMR evidence for the formation of 102 is shown in Figure 21 
with the key signals highlighted which correlated to reported literature data.71 The signal for H-3 has 
shifted upfield from 4.37 ppm to 4.10 ppm due to shielding effects of the benzyl while the other 
carbohydrate signals remain at similar chemical shifts to 69.  
 
 
Scheme 23: Reagents and conditions (a) BnBr, NaH, DMF, RT, 18 h 61% (b) i: H2O, 100°C, 18 h; ii: Ac2O, DMAP, 
DCM, RT, 17 h, 95% (c) 70% AcOH aq., RT, 18 h, 71%  
69         102  
103                         104 
Ph 
Figure 21: 1H NMR spectrum for compound 102 
H-1                      Ph-CH2      H-3 
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The presence of the benzyl group was confirmed by aromatic peaks between 7.23 and 7.39 ppm which 
integrate for 5 protons and the characteristic AB quartet at 4.71 ppm which integrated for 2 protons. 
This AB quartet splitting pattern is of particular importance especially in interpretation of the NMR 
spectra of products further along in this synthetic sequence.  
 
With the protected oxazoline 102 in hand, the challenge of selectivity cleaving the oxazoline and 
isopropylidene rings was addressed. A very interesting green chemistry article was published in 201372 
which used H2O as both reagent and solvent to achieve acetal cleavage without the use of catalysts or 
organic solvents. It was conjectured that the lability of the oxazoline ring, compared to that of the 
isopropylidene, could be exploited to achieve the desired selectivity particularly under such mild 
reaction conditions.  
 
Compound 102 was dissolved in a large excess of H2O and heated under reflux overnight producing a 
more polar compound, apparent from TLC. This was directly acetylated, for ease of purification and to 
be able to distinguish O-1 from O-5 and O-6, producing compound 103 in a 95% yield. The structure 
was confirmed through the analysis of 1H, 13C, COSY, HSQC and HMBC NMR spectra. Several identifying 
features of are shown in Figure 22.  
 
One of the most notable peaks is a broad doublet at 5.82 ppm in A, which couples to H-2 in B, and also 
couples to a quaternary carbon and a CH3 in C, suggesting the presence of an NHAc group at C-2. This is 
supported by the signal for H-2 appearing further downfield than in 102. The anomeric doublet has 
shifted slightly downfield (A) and cross peaks to a quaternary carbon and a CH3 signal (C) confirm that 
there is an acetate group at O-1. The acetate groups present at positions 1 and 2 prove that the oxazoline 
ring was indeed cleaved and two methyl signals at 1.40 and 1.35 ppm verified that the isopropylidene 
ring is still intact. Another cross peak shown in C shows the coupling between C-3 and the benzylic CH2 
group and is again confirmation that the benzyl group is indeed at position 3. These data supports the 
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OAc            NHAc 
1, 2 
C-3, Ph-CH2 
H-1   NHAc
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With C-1, C-2 and C-3 protected, the cleavage of the isopropylidene protecting group was investigated 
in order to prepare the molecule for selective protection of the primary hydroxyl at C-6 and inversion 
of configuration at C-5. This was accomplished by acid hydrolysis71 using 70% AcOH to produce diol 
104 in a 71% yield after column purification. The 1H NMR spectrum of this product showed that the two 
methyl peaks were absent and the signals for H-5 and both H-6 protons were shifted upfield. These data 
correlate to the loss of the isopropylidene group and confirm the formation of 104. 
 
3.4 Protection of Primary Hydroxyl 
In an initial attempt by a student, in the Gammon research group, to selectively protect O-6 of compound 
104 with a TMDBS group, an unusual product was isolated with no evidence for the 6-silyl ether 105. 
The product was identified as 1,6-anhydro glucofuranose 106 (Scheme 24) by analysis of a series of 2D 
NMR experiments (Figure 22). The most interesting and prominent feature was the anomeric signal 
which appeared as a singlet, shifted significantly further upfield than usual at  
5.02 ppm. The COSY spectrum in showed that the typical H-1, H-2 coupling is not seen. However, long 
range W-coupling from H-1 to H-4 and H-6b is observed as well as U-coupling (couplings across U-
shaped HCCCH fragments73) to H-3. These coupling patterns are typical of bicyclic systems which 
suggested that this product was a 1,6-anhydro sugar. Increased splitting of the benzylic CH2 signals and 
the fact that the H-6 protons give two distinct peaks support the notion since the molecule is more rigid. 
H-2 only couples to H-3 and NHAc suggesting that is has a 90° dihedral angle with H-1. These data in 
combination with the loss of the anomeric acetate signal suggests that the product was bicyclic 
compound 106.  
Scheme 24: Reagents and conditions for attempted synthesis of 105 showing unusual isolated product 106  
(a) TBDMSCl, DCM, DMAP 











104  106  





As shown in Figure 24 B the ball and stick model of 104, O-6 and C-1 are in fact ideally lined up for the 
ring closure to occur forming 106. Although only 10% of this product was obtained, the structure could 
potentially be useful in the inversion of C-5 since it is left exclusively unprotected. The optimal 
conditions for the formation 106 were thus investigated.  
 
The reaction was repeated under the same reaction conditions treating 104 with TBDMSCl in DCM and 
DMAP, a substitute for pyridine. After purification two compounds were islolated and it was found that 











































































  Figure 24: (A) Skeletal structure of 104 (B) ball and stick model of 104 (C) skeletal structure of 106 (D) ball and 




























































both 105 and 106 had formed. Interestingly, the major product was the silyl ether 105 while again only 
10% of 106 formed.  
 
It was initially thought that the ring closure was being mediated by the base DMAP. The reaction was 
therefore attempted under the same conditions but without the TBDMSCl (Table 3, Appendix).  
However, after two attempts only starting material was recovered from the reaction. A stronger base, 
NaH, was employed and after 18 h a very polar compound had formed which was directly acetylated for 
ease of purification. This product was not the desired 106 but the diol had been acetylated giving a tri-
acetylated product. A review of the literature showed that lewis acid mediated formations of 1,6-
anhydro rings in sugars74–83 are generally more common than base mediated reactions. A series of 
reactions using TMSOTf, BF3.Et2O and SnCl4 were therefore attempted (Table 3, Appendix). 
 
All three lewis acids were successful in converting 104 to 106 in varying yields however, unreacted 
starting material also remained which made the purification very difficult due to their similar polarities. 
The product from the TMSOTf reaction was isolated in a 12% yield and 29% starting material recovered. 
NMR analysis of the product from the BF3.Et2O reaction indicated a mixture of starting material and 1,6-
anhydro product with a combined yield of 68% (by mass). Attempts to separate these were 
unsuccessful. The reaction using SnCl4 also produced an inseparable mixture of 104 and 106 in a 1:1 
ratio with a yield of 35% (by mass). Finally, it was postulated that the bulky TBDMS group at O-6 in 
compound 105 might have assisted in the ring closure. Thus 105 was treated with TMSOTf which was 
the most successful reaction forming 106 in a 26% yield and recovering starting material (43%) and 
diol 104 which had lost the TBDMS group (22%). 
 
Although the desired 1,6-anhydro compound 106 was successfully synthesised the yield was not able 
to be increased and was very difficult to isolate as a pure product ultimately making this route unfeasible 
for the synthesis of L-AltNAcA. Attention was therefore shifted to improving the yield of the silyl ether 
105, which also leaves C-5 selectively unprotected which can then be selectively inverted. 
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The silylation was repeated using pyridine as the solvent since the DMAP and DCM combination lead to 
the formation of 106. Diol 104 was treated with TBDMSCl in pyridine and stirred for 24 h after which 
starting material was still present and so a second equivalent of TBDMSCl was added. This resulted in 
the successful synthesis of mono-protected silyl ether 105 in a 98% yield.  
The structure of 105 was quickly confirmed by two identifying signals in its 1H NMR spectrum (Figure 
25) corresponding to the TBDMS structure. A singlet at 0.89 ppm integrating for 9 protons correlated to 
t-butyl. The singlet further upfield integrated for 6 protons confirming the presence of the two methyls 
on Si. A notable feature of this spectrum is the splitting of the AB quartet signal from the benzylic CH2 
group. This kind of signal separation occurs when the free rotation of the molecule is reduced. The bulky 
TBDMS group at O-6 adds a significant amount of steric strain to the molecule which reduces the amount 
of free rotation that can occur resulting in the increased separation of the AB quartet to the point where 
two chemical shifts are observed for each half of the quartet.  
 
3.5 Attempted Inversion of C-5 
After efficiently and selectively protecting O-6, the inversion of configuration at C-5 was investigated. 
The proposed sequence (Scheme 25) follows a trilfation and nucleophilic substitution with NaOBz.  
 
Figure 25: 1H NMR spectrum for compound 105 
H-1               Ph-CH2                       H-6       C(CH3)3   Si(CH3)2 
Scheme 25: Reagents and conditions (a) Tf2O, py (b) NaOBz, DMF 
105                   107                            108 
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Since the molecule is already under steric strain, the likelihood of adding another bulky group at O-5 
was tested before attempting the trilfation. Since an acetylation reaction follows a similar mechanism 
to the triflation it was used as a feasibility test for this sequence 
 
105 was treated with Ac2O in pyridine and was successfully acetylated at O-5 after heating the reaction 
to 60°C overnight. Fully protected compound 109 was produced in a 91% yield. NMR analysis indicated 
an additional CH3 peak at 1.91 ppm and a downfield shift in the signal for H-5 while the other peaks 
remain at very similar chemical shifts to 105. This proved that O-5 could be manipulated even though 
the molecule is fairly crowded. This reaction also verified that the TBDMS group was indeed at position 
6. 
 
3.5.1 Attempted triflation of O-5 
Since the ultimate goal was to invert C-5, the hydroxyl needed to be converted to a good leaving group 
preparing the molecule for an SN2 substitution which will effectively invert the configuration.36,54,55,57,58 
Silyl ether 105 was treated with Tf2O in pyridine and after increasing the reaction temperature to  60°C 
(Table 4, Appendix) a single, less polar product formed.  
 
NMR analysis of the product was encouraging indicating a key downfield shift in the signal for H-5 
(Figure 26) to a similar position to its occurrence in the spectrum of 109. However, there appeared to 
be a pyridine contamination in the product due to three signals in the aromatic region of the 1H NMR 
spectrum, the doublet and two triplets are typical of a pyridine molecule (Figure 26). In an attempt to 
remove the pyridine, the work up conditions were changed (Table 4, Appendix) and toluene was used 
to remove it azeotropically but the signals were still present. It was then noted that the pyridine was 
Scheme 26: Reagents and conditions for acetylation (a) Ac2O, py, 60°C, 18 h, 91% 
105      109 
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present in a stoichimetric amount, integrating for 5 protons, and the chemical shift values of 8.92, 8.36 
and 7.88 ppm did not match literature values for pyridine. Another prominent feature seen in the 1H 
NMR spectrum is the wide separation of the two benzylic protons which appear as a split AB quartet 
indicating that they are in quite different chemical environments, suggesting increased steric strain in 
the product. This suggested that a larger group has been added to O-5. The TBDMS, NHAc and OAc 
groups at positions 6, 2 and 1 respectively were all present as evident from 1H NMR and confirmed by 
COSY and HSQC.  
 
Further structural analysis using 2D NMR lead to proposing the 
unusual structure 110 (Figure 27). Of particular significance was a 
clear connection between the proton and carbon signals for pyridine 
and position 5. These are highlighted in an overlay of the HSQC 
(orange) and HMBC (grey) spectra in Figure 28. There is a cross peak 
between C-5 and the pyridine protons ‘H-2’, and another cross peak 
between H-5 and the pyridine carbons ‘C-2’ seen in the grey HMBC spectrum. Since there is such a strong 
correlation it is very unlikely that there is an oxygen at C-5 and the proposed structure therefore has the 
pyridine nitrogen bonded directly to C-5. 19F NMR indicated a single peak at -78.27 ppm consistent with 
the presence of a triflate, suggesting that -OTf was the counter ion. HRMS analysis supported the 
proposed structure with the M+ ion at 529.2735 correlating to the cation component of 110.  
 
Figure 26: 1H NMR for unknown product 
Figure 27: Proposed structure 
110 
Pyridine-like peaks         





It seems likely that the triflate formed by the reaction at O-5 is highly reactive due to the sterically 
crowded environment. It therefore departs immediately either in an SN1 or SN2 process, to be replaced 
by the pyridine, which is present in large excess. 
 
It was evident from product 110 that an alternate solvent to pyridine was necessary. Four other solvent 
systems were tried namely DMAP in DCM, 2,6-lutidine, N-methylmorpholine and THF, but none were 
successful in synthesising triflate 107. The evidence from this set of experiments illustrates that the 
triflation does work but it immediately departs or is displaced by another nucleophile. It was therefore 
proposed that if NaOBz was added to the reaction at the correct time then it could displace the triflate 
forming the desired compound 108.  
3.5.2 Attempted one-pot triflation and inversion at C-5 
In this set of experiments (Table 5, Appendix) DMF and DCM were used as solvents and only a minor 
amount of pyridine added as a base in order to avoid displacement of the triflate with pyridine. The 
Figure 28: Spectra overlay showing HSQC (orange) and HMBC (grey) for compound 110 
C-5, py-H 5 
py py-C, H-5 
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reaction was initially attempted in DMF in which dissolved starting material 105 was treated 
sequentially with Tf2O and NaOBz. The crude product was analysed by NMR but there was no evidence 
for the formation of compound 108 but rather the TBDMS group at O-6 had been removed. The reaction 
was then repeated using DCM for the triflation and DMF for the nucleophilic substitution but this 
resulted in complete degradation of the carbohydrate material. This was observed in the NMR spectrum 
of the crude product which showed no carbohydrate residue but peaks that resembled TBDMS, acetate 
and benzyl group were seen which suggested that the compound fragmented. The reaction was tried at 
different temperatures and varying work up conditions but none were successful. In a final attempt, the 
pyridine compound 110 was treated with NaOBz in DMF to try and displace the pyridine at C-5 with a 
benzoyl group. Since the configuration of at C-5 in this compound is unknown the product could be the 
desired compound 108 or its diastereomer. Unfortunately this reaction also degraded leaving no 
evidence of a carbohydrate residue. 
 
At this point the synthetic route was re-evaluated as the triflate was evidently too reactive and unstable 
to effect the desired inversion. A mesylate was selected since it is also an effective leaving group but not 
as reactive as a triflate which would make the product stable enough to isolate and use in subsequent 
steps (Scheme 27). 
Scheme 27: Reagents and conditions (a) MsCl, py, -10°C, 8 h, 61% (b) NaOBz, DMF (c) NaOMe, MeOH, (d) TFA 
108                   112                          113 
105                      111 
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Alcohol 105 was treated with MsCl in pyridine and the desired mesylate 111 was isolated in a 61% yield 
after purification. The structure was confirmed by NMR analysis and attention is drawn to two features 
(Figure 29).  A peak resonating at 3.01 ppm which integrated for 3 protons had appeared in the 1H 
spectrum corresponding to the mesylate CH3. A significant downfield shift in the signal for H-5 from 4.00 
to 4.94 ppm was observed which is similar to that in the acetylated 109 confirming the position of the 
mesylate. In addition to this, the further separation of the benzylic CH2 AB quartet was observed which 
is expected as the steric congestion in molecule increases. 
 
3.5.3 Attempted inversion of C-5 
With the much desired mesylate 111 in hand the inversion at C-5 was reattempted. 111 was dissolved 
in DMF and treated with NaOBz at RT but after no reaction occurred and all the starting material was 
recovered. The reaction was repeated at 100°C but still no reaction occurred (Table 6). A solubility test 
was done with NaOBz as it appeared not to dissolve in DMF even at raised temperatures. Although it did 
Figure 29: COSY spectrum of compound 111 




not dissolve completely in any standard organic solvent, acetone and pyridine were the most promising. 
The experiment was repeated under reflux conditions but neither solvent was successful in effecting the 
desired substitution. The more reactive LiOBz, which was formed in situ using n-BuLi, was therefore 
used in an attempt to make the benzoyl anion more accessible. The reaction was unsuccessful leading 
not to the desired product but rather complete degradation of the starting material.  
 
It was possible that the bulky benzoyl group simply would not fit in the already congested molecule so 
a final attempt to invert the centre was done using NaOPiv, a smaller nucleophile. This reaction was 
performed in DMF at RT and when no reaction occurred, heated to 100°C, but unfortunately this again 
resulted in complete degradation of the carbohydrate, evident from NMR.  
 
Despite the fact many groups have published successful inversions by this method on both furanose and 
pyranose rings,36,54,55,57,58 after these experiments it was apparent that the inversion of configuration via 
and SN2 mechanism was not working. This suggests that this particular molecule made the inversion 
unsuccessful. A more thorough analysis of mesylate 111 indicated that C-5 is simply under too much 
steric strain to allow for an SN2 substitution to occur at that centre. The cis orientation of C-1 and -2, and 
C-3 and-4 respectively creates steric strain around the furanose ring. In addition to the fact that the 
substituents at C-3 and C-4 are eclipsed, they are also very bulky. The steric congestion at C-5 is probably 
influenced more by the TBDMS group at the adjacent carbon 6 than the benzyl at O-3 but both contribute 
to the amount of steric strain in the molecule. In addition, both the benzoyl and pivaloate groups are 
bulky nucleophiles which only add to the steric issues in this system. These factors make the inversion 










Conclusions and Future Work 
The aim of this project was to contribute to the preparation of a glycoconjugate vaccine candidate for S. 
sonnei by synthesising a suitable derivative of the acidic sugar, L-AltNAcA, found in the repeating unit of 
S. sonnei. Two synthetic routes were proposed starting from readily available D-sugars diacetone-D-
glucose (20) and N-acetal-D-glucosamine (69) which introduced the challenge of inverting the 
configuration at C-5. 
 
The first route followed an established synthesis45,47,59 which successfully converted 20 to L-sugar 1,6-
anhydro-3-O-benzyl--L-idopyranose (59) in 6 steps with an overall yield of 20%. The inversion of 
configuration at C-4 was then attempted via a triflation and substitution with a benzoyl group59 but this 
was unsuccessful. Alternative methods for efficiently discriminating between the three hydroxyl groups 
in 58 were then investigated which would allow for the selective inversion of the configuration at C-4 
and converting the hydroxyl at C-2 to the desired acetamido group. The most selective reaction in this 
investigation was a tin-mediated benzoylation in which a major product 1,6-anhydro-3-O-benzyl-4-O-
benzoyl--L-idopyranose (93) was produced in a 45% yield compared to 11% or less for the other 
benzoylated products. Unfortunately while this outcome showed good selectivity it was not useful 
synthetically since it was not able to be isolated as a pure compound. While this synthetic route 
successfully inverted the configuration at C-5 affording the desired L-configuration, the three hydroxyl 
groups in 58 could not be sufficiently differentiated to convert it to the desired L-AltNAcA. 
 
The emphasis in the second route was placed on the inversion of C-5 since the 2-acetamido group was 
already in place. 69 was converted to 2-acetamido-2-deoxy-3-O-benzyl-6-O--D-glucofuranosyl acetate 
104 in a 41% yield over four steps which was a key synthetic intermediate towards the inversion of 
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configuration at C-5. Although this inversion was not achieved, good insight into the reactivity of the 
diol 104 was gained. The selective protection of the primary hydroxyl O-6 with a TBDMS group was 
achieved in a 98% yield which left 5-OH selectively unprotected (105).  During this study, an unusual 
minor side-product was isolated and identified as 1,6-anhydro-2-acetamido-O-acetyl-2-deoxy-3-O-
benzyl--D-glucofuranose (106). This product formed from both 104 and 105 under acidic conditions 
but its formation was promoted by the presence of the TBDMS group at O-6. While this was a potentially 
useful intermediate, also having 5-OH selectively unprotected, it was only able to be synthesised in 
minor amounts and very difficult to isolate as a pure compound and was thus not synthetically useful. 
Inversion of configuration at C-5 in the 6-O-silylated glucofuranose was attempted via the 5-O-triflate 
and 5-O-mesylate: the triflate formed but was immediately displaced by the solvent pyridine to give an 
unusual 5-pyridinium derivative (110), while the mesylate was stable but unreactive towards 
subsequent SN2 inversion. These outcomes were attributed to the steric congestion imposed by the 
combination of the 3,4-cis-disubstitution of the furanose ring and the very bulky silyl substituent at O-
6. The presence of the silyl ether was a common characteristic of the formation of both unusual products 
106 and 110, and the failure of the SN2 substitution at C-5. This protecting group creates a significant 
amount of steric strain that the molecule which encourages the elimination of a group in order to reduce 
this high energy state. This was observed in the formation of the 1,6-anhydro ring in 106 which 
eliminated the TBDMS group, in the immediate displacement of the triflate from C-5 in the attempted 
synthesis of 107 and in the failure of the displacement of the mesylate in 111 by the benzoyl group. 
Therefore, this bulky silyl group was ultimately identified as a hindrance in the attempts to invert the 
configuration at C-5.  
While the goal of preparing L-AltNAcA was not achieved via these approaches, useful insights 
have been contributed towards the ongoing study. In future studies, diol 104 is a useful intermediate 
that could be converted to the desired L-sugar by a stereoselective reduction at C-5 and oxidation, or a 
triflation and inversion which would essentially only invert C-5 since C-6 is a primary hydroxyl, or by a 
Mitsunobu reaction. Once the inversion of configuration at C-5 is achieved the compound could be 







All reagents were used as received from Sigma Aldrich or Carbosynth unless stated otherwise. 
Anhydrous pyridine, CH3CN, DMF, and THF were used as acquired from Sigma Aldrich; all other solvents 
were dried and purified by distillation before use. Aluminium backed pre-coated Merck TLC plates of 
silica gel (60 F254) were used to monitor reactions and determine suitable solvents systems for column 
purification. The compounds were visualised on the TLC plates using UV light and/or by spraying them 
with CAS or anisaldehyde solutions and then heated. Column chromatography for purification of 
products was either performed manually or by flash chromatography using a Biotage Isolera™ Spektra 
System with ACI™. Both types of column used Merck Silica Gel (60, 70-230 mesh) and were eluted with 
mixtures of EtOAc and hexane or MeOH and DCM. Further separations were carried out using glass 
backed preparative TLC plates using mixtures of EtOAc and hexane or MeOH and DCM. 1H, 13C, COSY, 
HSQC and HMBC NMR spectra were recorded on Bruker Avance III 600 MHz NMR spectrometer with 
BBO Prodigy cryoprobe, Bruker BiospinGmbH 400 MHz, Varian Unity XR400 MHz and Varian Mercury 
XR300 MHz instruments as CDCl3 solutions unless stated otherwise. All chemical shifts are reported in 
ppm, with reference to the methine signal (δ 7.26 ppm) for residual CHCl3 in the case of 1H spectra or 






Compound 20 (3.01 g, 11.5 mmol) was dissolved in CH3CN (70 mL) under Ar, powdered MS (4 Å) were 
added and the mixture stirred for 5 min. NBS (4.52 g, 25.4 mmol) and PPh3 (6.66 g,  
25.4 mmol) were then added and the reaction refluxed at 80°C for 20 h. The reaction mixture was diluted 
with Et2O and filtered through celite® twice. The product was purified by flash column chromatography 
using 10-30% EtOAc in hexane as eluent to give 6-bromo-1,2:3,5-di-O-isopropylidene-α-D-
glucofuranoside (21) as a yellow oil (2.59 g, 69.6%).  
 
Rf in 40% EtOAc/hexane is 0.69. 1H NMR (400 MHz, CDCl3) δ 5.99 (d, J = 3.7 Hz, 1H, H-1), 4.58 (d,  
J = 3.7 Hz, 1H, H-2), 4.32 (dd, J = 7.2, 3.9 Hz, 1H, H-4), 4.23 (d, J = 3.9 Hz, 1H, H-3), 3.74 (td, J = 7.3, 
 3.3 Hz, 1H, H-5), 3.61 (dd, J = 10.9, 3.3 Hz, 1H, H-6a), 3.43 (dd, J = 10.9, 7.4 Hz, 1H, H-6b), 1.50 (s, 3H, 
CH3), 1.39 (s, 3H, CH3), 1.37 (s, 3H, CH3), 1.33 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3) δ 112.5 (C), 106.5 
(C-1), 101.55(C), 84.1 (C-2), 81.7 (C-4), 75.2 (C-3), 72.1 (C-5), 33.2 (C-6), 27.3 (CH3), 26.7 (CH3), 24.1 




Compound 21 (1.76 g, 5.44mmol) was dissolved in dry DMF (10 mL) under Ar and cooled to 0°C. NaH, 
60% mineral oil dispersion, (0.87 g, 21.7 mmol) was added to the reaction mixture which was then 
stirred for 16 h while slowly warming to RT. The reaction mixture was then cooled to 0°C again and 
brine added to the flask. The aqueous layer was then extracted with EtOAc (3 x 30 mL) and dried over 
anhydrous Na2SO4. Purification of the product was carried out by flash column chromatography in a 
gradient of 2 to 30% EtOAc in hexane as eluent to afford 6-deoxy-1,2:3,5-di-O-isopropylidene-α-D-xylo-
hex-5-enofuranoside (22) as a light yellow oil (1.25 g, 95.1%).  
 
Rf in 40% EtOAc/hexane is 0.54. 1H NMR (300 MHz, CDCl3) δ 5.98 (d, J = 3.7 Hz, 1H, H-1), 4.76 (d,  
J = 0.7 Hz, 1H, H-6a), 4.69 (d, J = 0.7 Hz, 1H, H-6b), 4.56 (dd, J = 3.8 Hz, 1H, H-2), 4.37 (d, J = 2.4 Hz, 1H, 
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H-3), 4.34 (d, J = 2.4 Hz, 1H, H-4), 1.53 (s, 3H, CH3), 1.47 (s, 3H, CH3), 1.40 (s, 3H, CH3), 1.33 (s, 3H, CH3). 
13C NMR (101 MHz, CDCl3) δ 150.3 (C-5), 111.8 (C), 105.2 (C-1), 101.3 (C-6), 100.5 (C), 84.3  
(C-2), 74.7 (C-4), 72.4 (C-3), 28.0 (CH3), 26.7 (CH3), 26.1 (CH3), 21.2 (CH3). These data are in agreement 




Compound 3 (5.89 g, 24.3 mmol) was dissolved in THF and a 1M BH3.THF complex (26.2 mL, 26.8 mmol) 
was added to this under Ar at RT. The reaction was stirred for 3.5 h and was then cooled to 0°C before 
slowly adding a mixture of 30% H2O2 (v/v) and 3M NaOH (1:1, 20 mL). The aqueous layer was then 
extracted with EtOAc (3 x 50 mL). The combined organic layers were subsequently washed with brine 
and dried over anhydrous Na2SO4. The product was purified by flash column chromatography in a 
gradient from 5 to 50% EtOAc in hexane as eluent to give 1,2:3,5-di-O-isopropylidene--L-idofuranoside 
(23) as a colourless oil (4.49 g, 71.0%).  
 
Rf in 40% EtOAc/hexane is 0.33. 1H NMR (400 MHz, CDCl3) δ 5.94 (d, J = 3.7 Hz, 1H, H-1), 4.48 (d,  
J = 3.7, 1H, H-2), 4.30 (d, J = 2.3 Hz, 1H, H-3), 4.11 (m, 1H, H-5), 4.01 (t, J = 2.2 Hz, 1H, H-4), 3.88 (ddd,  
J = 11.5, 6.9, 3.2 Hz, 1H, H-6a), 3.79 (ddd, J = 11.6, 8.5, 4.7 Hz, 1H, H-6b), 1.48 (s, 3H, CH3), 1.45 (s, 3H, 
CH3), 1.40 (s, 3H, CH3), 1.31 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3) δ 111.9 (C), 105.4 (C-1), 98.3 (C), 
84.0 (C-2), 74.1 (C-3), 71.9 (C-4), 69.2 (C-5), 63.3 (C-6), 29.3 (CH3), 26.8 (CH3), 26.2 (CH3), 19.3 (CH3). 






A solution of 23 (1.23 g, 4.72 mmol) in 0.2 M ethanolic HCl (40 mL) was refluxed at 95°C for 17 h. After 
cooling the reaction mixture to RT it was neutralized using NaHCO3 (0.80 g) and filtered through celite® 
to remove residual salts. The filtrate was concentrated and purified by flash column chromatography in 
a gradient from 2 to 10% MeOH in EtOAc as eluent to afford the 1,6-anhydro--L-idopyranose (58) as a 
colourless oil (0.62 g, 80.0%).  
 
Rf in 10% MeOH/EtOAc is 0.14. 1H NMR (300 MHz, (CD3)2CO) δ 5.15 (d, J = 1.8 Hz, 1H, H-1), 4.45 (d,  
J = 4.4 Hz, 1H, 4-OH), 4.32 (t, J = 5.0 Hz, 1H, H-5), 4.24 (d, J = 4.9 Hz, 1H, 3-OH), 4.04 (d, J = 6.7 Hz, 1H,  
2-OH), 3.96 (d, J = 7.4 Hz, 1H, H-6a), 3.64 (m, 1H, H-4), 3.58 (m, 1H, H-6b), 3.47 (td, J = 8.0, 4.8 Hz, 1H, H-
3), 3.33 (ddd, J = 8.2, 6.6, 1.8 Hz, 1H, H-2). 13C NMR (101 MHz, (CD3)2CO) δ 103.2 (C-1), 76.6 (C-5), 76.5 
(C-2), 76.5 (C-3), 72.8 (C-4), 65.4 (C-6). These data are in agreement with literature data.59 
 
Attempted synthesis of 1,6-anhydro-3-O-benzyl--L-idopyranose (59) 
 
Silyl ether 82 (1.01 g, 2.65 mmol) was dissolved in DCM (20 mL) under Ar at RT and stirred for  
5 min. This was cooled to 0°C and 4 Å MS added and the mixture stirred for 30 min after which 
benzaldehyde (0.32 mL, 3.18 mmol) was added. The reaction was cooled to -78°C and TMSOTf (0.05 mL, 
0.26 mmol) was added. The reaction was stirred at that temperature for 1 h. SiHEt3 (0.12 mL, 0.75 mmol) 
was added and the reaction allowed to warm to RT over 1 h with stirring. A 1M solution of TBAF in THF 
(0.58 mL, 2.01 mmol) was added dropwise and the reaction stirred for a further 1.5 h. Solid NH4Cl         
(0.1 g) was added and the resultant mixture filtered through celite. The filtrate was washed with brine 
and the combined organic layers concentrated under reduced pressure. The crude product showed 
three UV active spots on TLC that stained with CAS. These were separated by column chromatography 
in a gradient solvent system of 20-65% EtOAC in hexane to product; 1,6-anhydro-3-O-benzyl-β-L-
idopyranose (59) (0.28 g, 42.5%) as a white solid, 1,6-anhydro-2,3-di-O-benzyl-β-L-idopyranose (83) 
(0.184.3 g, 20.3%) as white powder and 1,6-anhydro-3,4-di-O-benzyl-β-L-idopyranose (84) (0.07 g, 




59: Rf in 40% EtOAc/hexane run twice is 0.32. m.p. 140-144°C. 1H NMR (300 MHz, CDCl3) δ 7.39 – 7.27 
(m, 5H, Ph-H), 5.27 (d, J = 2.1 Hz, 1H, H-1), 4.85 (AB q, J = 11.6 Hz, 2H, CH2-Ph), 4.44 (t, J = 4.6 Hz, 1H, H-
5), 4.06 (dd, J = 7.7, 0.8 Hz, 1H, H-6a), 3.88 (ddd, J = 8.2, 4.3, 1.1 Hz, 1H, H-4), 3.68 (ddd, J = 7.9, 5.1, 1.1 
Hz, 1H, H-6b), 3.63 (dd, J = 7.7, 2.0 Hz, 1H, H-2), 3.42 (t, J = 7.9 Hz, 1H, H-3). 1H NMR (300 MHz, (CD3)2CO) 
δ 7.43 – 7.36 (m, 2H, Ph-H), 7.35 – 7.23 (m, 3H, Ph-H), 5.17 (d, J = 1.7 Hz, 1H, H-1), 4.86 (AB q, J = 11.8 
Hz, 2H, CH2-Ph), 4.55 (td, J = 4.8, 0.9 Hz, 1H, 4-OH),  4.34 (d, J = 4.4 Hz, 1H, H-5), ), 4.14 (d, 
 J = 6.9 Hz, 1H, 2-OH), 4.03 (dd, J = 7.5, 0.8 Hz, 1H, H-6a), 3.81 (ddd, J = 7.5, 4.3, 1.1 Hz, 1H, H-4), 3.62 
(ddd, J = 7.6, 5.1, 1.1 Hz, 1H, H-2), 3.51 (dd, J = 7.4, 1.8 Hz, 1H, H-6b), 3.48 (t, J = 7.5 Hz, 1H, H-3). 13C NMR 
(101 MHz, (CD3)2CO) δ 140.7 (Ph-C), 128.8 (Ph-CH), 128.3 (PhCH), 127.9 (Ph-CH), 103.2 (C-1), 84.9 (C-
3), 76.6 (C-5), 76.3 (C-2), 75.0 (Ph-CH2), 72.4 (C-4), 65.4 (C-6). These data are in agreement with 
literature data. 59 
 
 
83: Rf in 40% EtOAc/hexane run twice is 0.56. m.p. 102-105°C. 1H NMR (600 MHz, (CD3)2CO) δ  
7.40 – 7.36 (m, 4H, Ph-H), 7.34 – 7.29 (m, 4H, Ph-H), 7.29 – 7.24 (m, 2H, Ph-H), 5.40 (d, J = 1.7 Hz, 1H, H-
1), 4.85 (AB q, J = 11.8 Hz, 2H, Ph-CH2), 4.72 (AB q, J = 12.0 Hz, 2H, Ph-CH2), 4.63 (d, J = 4.3 Hz, 1H,  
4-OH), 4.35 (td, J = 4.6, 0.9 Hz, 1H, H-5), 4.07 (dd, J = 7.5, 0.9 Hz, 1H, H-6a), 3.89 – 3.81 (m, 1H, H-4), 3.62 
(ddd, J = 8.2, 5.4, 1.4 Hz, 1H, H-6b), 3.59 (t, J = 8.1 Hz, 1H, H-3), 3.43 (dd, J = 8.0, 1.7 Hz, 1H,  
H-2).13C NMR (101 MHz, (CD3)2CO) δ 140.4 (Ph-C), 139.8 (Ph-C), 129.0 (Ph-CH), 128.9 (Ph-CH), 128.5 
(Ph-CH), 128.3 (Ph-CH), 128.2 (Ph-CH), 127.9 (Ph-CH), 100.3 (C-1), 83.5 (C-2), 83.5  





84: Rf in 40% EtOAc/hexane run twice 0.63. m.p. 71-73°C. 1H NMR (600 MHz, (CD3)2CO) δ 7.46 – 7.20 
(m, 10H, Ph-H), 5.18 (d, J = 1.9 Hz, 1H, H-1), 4.86 (AB q, J = 12.0 Hz, 2H, Ph-CH2), 4.73 (s, 2H, Ph-CH2), 
4.59 (t,  = 4.7 Hz, 1H, H-5), 4.24 (dd, J = 7.1, 0.9 Hz, 1H, 2-OH), 4.01 (d, J = 7.5 Hz, 1H, H-6a), 3.67 (ddd,  
J = 8.0, 4.2, 1.1 Hz, 1H, H-4), 3.63 (ddd, J = 7.5, 5.2, 1.1 Hz, 1H, H-6b), 3.59 (t, J = 7.9 Hz, 1H, H-3),  
3.54 (td, J = 7.5, 1.9 Hz, 1H, H-2). 13C NMR (101 MHz, (CD3)2CO) δ 140.4 (Ph-C), 139.7 (Ph-C), 129.1 (Ph-
CH), 128.9 (Ph-CH), 128.6 (Ph-CH), 128.3 (Ph-CH), 127.9 (Ph-CH), 103.1 (C-1), 83.9 (C-3), 80.0 (C-4), 





Compound 59 (0.06 g, 0.24 mmol) was dissolved in pyridine (0.5 mL) under Ar and stirred for  
5 min and cooled to 0°C. A solution of freshly distilled BzCl ( 0.03 mL, 0.25 mmol) in DCM (0.6 mL) was 
added to the reaction mixture and stirred at this temperature for 4 h. Tf2O (0.12 mL, 0.73 mmol) was 
added and the reaction kept stirring at RT for 1 h after which it was quenched with MeOH  
(0.5 mL). This was concentrated under reduced pressure and dissolved in water (4 mL) and then 
extracted with EtOAc (3 x 5mL). The combined organic layers were washed with 2M HCl then brine and 
subsequently dried over anhydrous Na2SO4. The concentrated residue was purified by column 
chromatography in a gradient from 20 – 30% EtOAc/hexane to afford two products. The desired  
1,6-anhydro-2-O-benzoyl-3-O-benzyl-4-O-trifluoromethanesulfonyl-β-L-idopyranose (60) (0.07 g, 
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59.0%) as a yellow powder and a yellow oil (0.02 g) appeared to be degraded material containing no 
carbohydrate residue. 
 
Rf in 50% EtOAc/hexane run twice is 0.19. m.p. 76-80°C. 1H NMR (400 MHz, CDCl3) δ 8.02 (dd, J = 8.5, 
1.3 Hz, 2H, Bz-H), 7.61 (tt, J = 7.5, 1.2 Hz, 1H, Bz-H), 7.46 (td, J = 8.0, 0.3 Hz, 2H, Bz-H), 7.20 (d,  
J = 0.8 Hz, 5H, Bn-H), 5.59 (d, J = 1.8 Hz, 1H, H-1), 5.13 (dd, J = 8.1, 1.8 Hz, 1H, H-2), 5.04 (ddd, J = 8.4, 4.4, 
1.0 Hz, 1H, H-4), 4.80 (t, J = 4.6 Hz, 1H, H-5), 4.76 (d, J = 11.0 Hz, 1H, Bn-CH2), 4.68 (d, J = 11.1 Hz, 1H, Bn-
CH2), 4.21 (d, J = 8.7 Hz, 1H, H-6a), 4.16 (t, J = 8.3 Hz, 1H, H-3), 3.91 (ddd, J = 8.5, 4.9, 1.0 Hz, 1H, H-6b). 
13C NMR (101 MHz, CDCl3) δ 165.4 (C), 136.8 (C), 133.8 (CH), 130.0 (CH), 128.8 (C), 128.7 (CH), 128.5 
(CH), 128.2 (CH), 128.1 (CH), 118.5 (q, J = 319.7, 319.2 Hz, CF3), 99.5 (C-1), 83.9 (C-3), 76.9 (C-4), 76.6 





Compound 68 (5.03 g, 22.7 mmol) was dissolved in acetone (100 mL) dried over MS beads under Ar at 
RT. MS were added and stirred for 10 min before adding BF3.Et2O (8.42 mL, 68.2 mmol). The reaction 
was stirred under reflux for 3.5 h, cooled to RT and diluted with Et3N (31.9 mL, 227.5 mmol). This 
mixture was concentrated under reduced pressure and added to a solution of Na2CO3 (37.02 g) in water 
(250 mL), extracted with DCM (5 x 60 mL), dried over anhydrous Na2SO4 and concentrated under 
reduced pressure to give 2-methyl-(1,2-dideoxy-5,6-O-isopropylidene--D-glucofurano)-[2,1-d]-2-
oxazoline (69) (4.99 g, 90.1%) as a brown solid.  
 
Rf in 15% MeOH/EtOAc is 0.54. m.p. 112-116°C. 1H NMR (400 MHz, CDCl3) δ 6.13 (d, J = 5.1 Hz, 1H,  
H-1), 4.43 (dd, J = 5.1, 1.5 Hz, 1H, H-2), 4.37 (d, J = 2.8 Hz, 1H, H-3), 4.30 (ddd, J = 7.8, 6.2, 4.9 Hz, 1H,  
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H-5), 4.12 (dd, J = 8.7, 6.2 Hz, 1H, H-6a), 3.98 (dd, J = 8.7, 4.9 Hz, 1H, H-6b), 3.73 (dd, J = 7.8, 2.9 Hz, 1H, 
H-4), 2.00 (d, J = 1.6 Hz, 3H, C(CH3)2), 1.39 (d, J = 0.7 Hz, 3H, C(CH3)2), 1.33 (d, J = 0.7 Hz, 3H, NC(CH3)O). 
13C NMR (400 MHz, CDCl3) δ 166.9 (C(CH3)2), 124.3 (NC(CH3)O), 107.2 (C-1), 82.0  
(C-4), 78.3 (C-2), 74.9 (C-3), 73.19(C-5), 67.5 (C-6), 26.9 (C(CH3)2),25.27 (C(CH3)2), 14.22 (NC(CH3)O). 
HRMS calcd for C11H17NO5: 243.1107; found: 244.1186 [M+H]. 
 
Attempted synthesis of 6-Bromo-2-methyl-(-1,2,6-trideoxy-3,5-O-
isopropylidene--D-glucofurano)-[2,1-d]-2-oxazoline61 (70) 
 
General procedure, see Table 2 for details. Oxazoline 28 was dissolved in solvent under Ar and stirred 
for 10 mins.  NBS and PPh3 were added and the reaction stirred under reflux. Once TLC indicated the 
starting material was consumed, the reaction mixture was cooled to RT. It was then diluted with Et2O, 
filtered through celite and concentrated under reduced pressure. NMR of the crude material indicated 
that the no carbohydrate material was present, predominant peaks were aromatic, most likely PPh3O. 




Compound 59 (0.11 g, 0.43 mmol) was dissolved in DCM (4 mL) under Ar, anhydrous pyridine  
(0.5 mL) was added to increase solubility and the mixture cooled to 0°C. A solution of freshly distilled 
BzCl (0.05 mL, 0.45 mmol) was added to the reaction mixture slowly and stirred at this temperature for 
4 h. The reaction was quenched with MeOH (1 mL), concentrated under reduced pressure, and the 
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residue dissolved in water (4 mL) and then extracted with EtOAc (3 x 5mL). The combined organic layers 
were washed with 2N HCl, saturated NaHCO3, water and then brine and subsequently dried over 
anhydrous Na2SO4.The concentrated residue was purified by flash column chromatography in a gradient 
from 20 to 70% EtOAc in hexane as eluent to afford two compounds. The desired product, 1,6-anhydro-
2-O-benzoyl-3-O-benzyl--L-idopyranose (81) (0.03 g, 19.8%) as a yellow powder and recovered 
starting material (59) (0.04 g, 28.0%). 
 
Rf in 50% EtOAc/hexane is 0.36. m.p. 82-90°C. 1H NMR (300 MHz, (CD3)2CO) δ 8.02 (dd, J = 8.4, 1.3 Hz, 
2H, Bz-H), 7.66 (tt, J = 7.4, 1.4 Hz, 1H, Bz-H), 7.52 (t, J = 7.8, 7.3 Hz, 1H, Bz-H), 7.30 – 7.24 (m, 2H, Bn-H), 
7.22 – 7.16 (m, 3H, Bn-H), 5.46 (d, J = 1.8 Hz, 1H, H-1), 4.92 (dd, J = 8.4, 1.8 Hz, 1H, H-2,), 4.82 (AB q,  
J = 11.7 Hz, 2H, Bn-CH2), 4.49 (t, J = 4.5 Hz, 1H, H-5), 4.19 (dd, J = 7.6, 0.9 Hz, 1H, H-6a), 4.06 – 3.99 (m, 
1H, H-4), 3.88 (t, J = 8.2 Hz, 1H, H-3), 3.70 (ddd, J = 7.7, 5.1, 1.1 Hz, 1H, H-6b). 13C NMR (101 MHz, 
(CD3)2CO) δ 166.3 (C), 139.9 (C), 134.2 (CH), 130.8 (CH), 130.4 (C), 129.4 (CH), 128.9 (CH), 128.4 (CH), 
128.1 (CH), 100.0 (C-1), 80.9 (C-3), 77.5 (C-4), 76.8 (C-2), 75.0 (C-6), 72.8 (C-5), 65.7 (Bn-CH2). These 




Triol 58 (0.33 g, 2.04 mmol) was dissolved in DCM under Ar and cooled to 0°C before adding Et3N (1.42 
mL, 10.2 mmol). After slowly adding TMSCl (1.03 mL, 8.15 mmol) the reaction mixture was allowed to 
warm to RT and stirred for 4 h. The reaction mixture was concentrated and the residue dissolved in 
hexane before filtering through celite®. The residue was recrystallized from EtOH to produce 1,6-




Rf in 40% EtOAc/hexane is 0.74. m.p. 68-71°C. 1H NMR (300 MHz, CDCl3) δ 5.18 (d, J = 1.6 Hz, 1H, H-1), 
4.25 (t, J = 4.6 Hz, 1H, H-5), 4.07 (d, J = 7.6 Hz, 1H, H-6a), 3.68 (m, 1H, H-4) 3.67 (m, 1H, H-6b), 3.56 (t,  
J = 7.6 Hz, 1H, H-3), 3.46 (dd, J = 7.6, 1.6 Hz, 1H, H-2), 0.17 (s, 9H, Si(CH3)3), 0.14 (s, 9H, Si(CH3)3), 0.14 
(s, 9H, Si(CH3)3). 13C NMR (101 MHz, CDCl3) δ 102.3 (C-1), 76.6 (C-2), 76.6 (C-3), 75.9 (C5), 73.2 (C-4), 
65.2 (C6), 1.1 (CH3), 0.5 (CH3), 0.5 (CH3). These data are in agreement with literature data.59 
 
Attempted synthesis of 1,6-anhydro-2,4-di-O-benzoyl-3-O-benzyl--L-
altropyranose50 (85) 
 
Compound 60 (0.07 g, 0.15 mmol) was dissolved in DMF (4.5 mL) under Ar and cooled to 0°C. NaOBz 
(0.03 g, 0.23 mmol) was added and the reaction stirred at 0°C for 1 h, TLC showed little progress. The 
reaction was allowed to warm to RT for 5 h, but there was still very little reaction progress. It was then 
heated to 90°C for 3 h after which the TLC indicated that the reaction was finished. Brine solution was 
added to the reaction mixture and the resulting slurry extracted with DCM (3 x 10 mL). The combined 
DCM phases were dried over anhydrous Na2SO4, concentrated and then purified by flash 
chromatography in a gradient solvent system of 5 to 35% EtOAC in hexane, from which two compounds 
were identified. The less polar of the two was recovered starting material (0.03 g, 34%) which was 
confirmed by NMR. The more polar compound (0.02 g) was still not pure (NMR) so it was 
chromatographed further on a preparative TLC plate. Three separate UV active bands were seen on the 
plate and these were collected, extracted and analysed by NMR. The middle band (0.009 g) was the only 
one showing signals consistent with a carbohydrate derivative, though the sample was still clearly not 
a single compound. More purification lead to further degradation so this route was abandoned due to 




Attempted synthesis of 1,6-Anhydro-2,4-di-O-benzoyl-3-O-benzyl--L-
altropyranose84 
 
Compound 59 (0.06 g, 0.23 mmol) was dissolved in anhydrous THF (5 mL) under Ar. PPh3 (0.073 g, 
0.281 mmol) and benzoic acid (0.031g, 0.256 mmol) were added and the reaction mixture cooled to 0°C. 
DIAD (0.05 mL, 0.28 mmol) was added dropwise and the reaction mixture stirred at RT for  
18 h. TLC showed little reaction progress and so the temperature was increased to 60°C for 2 h. Almost 
no reaction progress was observed so the reaction was diluted with Et2O, the ether layer was washed 
twice with aqueous NaHCO3 and the separated aqueous portion back-extracted with Et2O. The combined 
organic layers were dried over anhydrous Na2SO4 and concentrated under reduced pressure. The 
residue was redissolved in Et2O and hexane then added in order to precipitate the solid PPh3O which 
was removed by filtration through celite. This organic filtrate was concentrated, and then purified by 
flash chromatography in a solvent gradient system of 25 to 65 EtOAc in hexane to recover only 
unreacted starting material (0.06 g, 100%). 
 
Attempted synthesis of 1,6-Anhydro-2-O-p-methoxybenzyl-3-O-benzyl--L-
idopyranose45 (87) 
 
Compound 59 (0.08 g, 0.33 mmol) was dissolved in DMF (1 mL) at RT under Ar. The reaction was cooled 
to 0°C and NaH, 60% mineral oil dispersion, (0.03 g, 0.7 mmol) added. PMBCl (0.05 mL, 0.37 mmol) was 
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added and the reaction mixture stirred at 0°C for 4 h. TLC showed slow reaction progress so the reaction 
was warmed to RT for 12 h. It was then quenched with MeOH (2 mL) and concentrated under reduced 
pressure. The residue was dissolved in EtOAc, washed with brine and saturated NaHCO3 and dried over 
anhydrous Na2SO4. Three UV active spots that also stained with CAS were identified on TLC of the crude 
product mixture. These were separated by column chromatography in a gradient solvent system of 20-
65% EtOAc in hexane. Starting material was recovered as a white powder (0.02 g, 27.3%), 1,6-Anhydro-
2,4-di-O-p-methoxybenzyl-3-O-benzyl--L-idopyranose (86) (0.08 g, 50.1%) afforded as a clear oil and 
a mixture of the 2 and 4-PMB products (87 and 88) (0.02 g, 19.3%) afforded as a pale yellow powder. 
 
 
87 and 88: Rf in 50% EtOAc/hexane run twice is 0.36. 1H NMR (300 MHz, (CD3)2CO) δ 7.42 – 7.21 (m, 
14H, Ar), 6.93 – 6.80 (m, 4H, Ar), 5.35 (d, J = 1.7 Hz, 1H. H-1), 5.17 (d, J = 1.6 Hz, 1H, H-1’), 4.92 – 4.78 
(m, 4H, Bn-CH2), 4.67 – 4.60 (m, 4H, PMB-CH2), 4.55 (ddd, J = 5.1, 4.2, 0.8 Hz, 1H), 4.39 – 4.30 (m, 1H), 
4.22 (d, J = 6.3 Hz, 1H), 4.05 (dd, J = 7.5, 0.8 Hz, 1H), 3.98 (dd, J = 7.4, 0.9 Hz, 1H), 3.78 (d, J = 1.0 Hz, 6H, 
Ph-OCH3), 3.63 (ddt, J = 6.5, 3.7, 1.2 Hz, 3H), 3.60 – 3.51 (m, 3H), 3.40 (dd, J = 8.0, 1.7 Hz, 1H). 
 
 
86: Rf in 50% EtOAc/hexane run twice is 0.29. 1H NMR (300 MHz, (CD3)2CO) δ 7.42 – 7.19 (m, 8H, PMB-
H), 6.95 – 6.82 (m, 5H, Bn-H), 5.35 (d, J = 1.7 Hz, 1H, H-1), 4.81 (s, 2H, Bn-CH2), 4.66 – 4.61 (m, 4H, PMB-
CH2), 4.55 (ddd, J = 4.9, 3.7, 0.8 Hz, 1H, H-5), 4.01 (dd, J = 7.5, 0.9 Hz, 1H, H-6a), 3.78 (d, J = 1.1 Hz, 6H, 




Attempted synthesis of 1,6-Anhydro-3-O-benzyl-2-O-trimethylsilyl-β-L-
idopyranose59 (89) 
 
Compound 59 (0.05 g, 0.21 mmol) was dissolved in DCM (1 mL) under Ar and cooled to 0°C. NEt3      
(0.037 mL, 0.27 mmol) was added to the reaction mixture followed by freshly distilled TMSCl  
(0.03 mL, 0.23 mmol). The reaction was stirred at 0°C for 5.5 h and then concentrated under reduced 
pressure. The residue was then dissolved in a minimum amount of DCM and, on addition of hexane the 
product crystallised and was recovered by filtration through fluted filter paper. NMR confirmed that it 
was recovered starting material (0.05 g, 99%). The reaction was repeated at RT with the same result. 
 
Attempted synthesis of 1,6-anhydro-2-O-benzoyl-β-L-idopyranose64 (92) 
 
Triol 58 (0.08 g, 0.49 mmol) and Bu2SnO (0.24 g, 0.98 mmol) were dissolved in dry PhCH3 (2 mL) and 
refluxed for 30 min under N2 after which time the water was azeotropically removed under reduced 
pressure. BzCl (0.12 mL, 1.04 mmol) in PhCH3 (3 mL) was added to the reaction mixture and stirred at 
RT for 18 h. The reaction mixture was then cooled to 0°C, quenched with EtOAc and filtered through 
celite. The solvents were removed under reduced pressure and the residue purified by column 
chromatography using 30 to 100% EtOAc in hexane as eluent to give 1,6-anhydro-2-O-benzoyl-β-L-
idopyranose (92) (0.02 g, 11%) and 1,6-anhydro-4-O-benzoyl-β-L-idopyranose (93) (0.06 g, 45%) as a 
1:4 mixture, and 1,6-anhydro-3,4-di-O-benzoyl-β-L-idopyranose (94) (0.02 g, 8%) and 1,6-anhydro-2,4-
di-O-benzoyl-β-L-idopyranose (95) (0.009 g, 5%) as a 3:2 mixture, and pure 1,6-anhydro-2,3,4-tri-O-
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benzoyl-β-L-idopyranose (96) (0.03 g, 11%) which were all obtained as white solids. In addition, 
starting material was recovered (0.01 g, 15%). 
 
92: Rf in 100% EtOAc is 0.44. m.p. 143-148°C. 1H NMR (400 MHz, CD3OD) δ 8.09 – 8.06 (m, 2H, Ph-H), 
7.61 (d, J = 7.4 Hz, 1H, Ph-H), 7.51 – 7.46 (m, 2H, Ph-H), 5.44 (d, J = 1.8 Hz, 1H, H-1), 4.81 (dd, J = 8.2, 1.8 
Hz, 1H, H-2), 4.45 (t, J = 4.4 Hz, 1H, H-5), 4.14 (dd, J = 7.6, 0.8 Hz, 1H, H-6a), 3.84 (t, J = 8.3 Hz, 1H,  
H-3), 3.78 (ddd, J = 8.3, 4.2, 1.1 Hz, 1H, H-4), 3.71 (ddd, J = 7.7, 5.1, 1.1 Hz, 1H, H-6b). 13C NMR (101 MHz, 
CD3OD4) δ 167.6 (C=O), 134.4 (Ph-C), 130.7 (Ph-C), 129.5 (Ph-C), 100.6 (C-1), 78.6 (C-2), 77.2 (C-5), 73.3 
(C-3), 73.0 (C-4), 66.1 (C-6). HRMS calcd for C13H14O6: 266.0790; found: 267.0871 [M+H]. 
 
 
93: Rf in 100% EtOAc is 0.44. m.p. 121-126°C. 1H NMR (400 MHz, CD3OD) δ 8.09 – 8.06 (m, 2H, Ph-H), 
7.61 (d, J = 7.4 Hz, 1H, Ph-H), 7.51 – 7.46 (m, 2H, Ph-H), 5.32 (d, J = 1.9 Hz, 1H, H-1), 5.07 (ddd, J = 8.7, 
4.2, 1.1 Hz, 1H, H-4), 4.68 (t, J = 4.6 Hz, 1H, H-5), 4.13 (dd, J = 7.9, 0.8 Hz, 1H, H-6a), 3.89 (t, J = 8.3 Hz, 1H, 
H-3), 3.75 (ddd, J = 8.0, 5.0, 1.2 Hz, 1H, H-6b), 3.68 (t, J = 5.0 Hz, 1H, 2-OH), 3.53 (dd, J = 8.4, 1.8 Hz, 1H, 
H-2). 13C NMR (101 MHz, CD3OD) δ 165.9 (C=O), 133.1 (Ph-C), 129.3 (Ph-C), 128.2 (Ph-C), 102.2 (C-1), 




94: Rf in 100% EtOAc is 0.58. m.p. 95-100°C. 1H NMR (400 MHz, (CD3)2CO) δ 8.09 – 8.02 (m, 4H, Ph-H), 
7.66 – 7.62 (m, 2H, Ph-H), 7.53 – 7.49 (m, 4H, Ph-H), 5.59 (d, J = 1.8 Hz, 1H, H-1), 5.24 (ddd, J = 8.7, 4.3, 
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1.2 Hz, 1H, H-4), 5.00 (dd, J = 8.4, 1.8 Hz, 1H, H-2), 4.84 (t, J = 4.7 Hz, 1H, H-5), 4.43 (t, J = 4.9 Hz, 1H,  
H-3), 4.32 (dd, J = 8.0, 0.8 Hz, 1H, H-6a), 3.81 (ddd, J = 8.1, 4.9, 1.3 Hz, 1H, H-6b), 3.76 (t, J = 5.0 Hz, 1H, 
3-OH). 13C NMR (101 MHz, (CD3)2CO) δ 167.5 (C=O), 160.72 (C=O), 133.7 (Ph-C), 130.4 (Ph-C), 129.3 
(Ph-C), 100.3 (C-1), 78.4 (C-2), 74.8 (C-4), 73.8 (C-5), 66.6 (C-6), 64.9 (C-3). HRMS calcd for C20H18O7: 
370.1053; found: 371.1125 [M+H]. 
 
 
95: Rf in 100% EtOAc is 0.58. m.p. 134-138°C. 1H NMR (400 MHz, (CD3)2CO) δ 8.09 – 8.02 (m, 4H,  
Ph-H), 7.66 – 7.62 (m, 2H, Ph-H), 7.53 – 7.49 (m, 4H, Ph-H), 5.29 (d, J = 1.8 Hz, 1H, H-1), 5.23 (t, J = 8.4 
Hz, 1H, H-3), 4.49 (t, J = 4.7 Hz, 1H, H-5), 4.19 (dd, J = 7.7, 0.8 Hz, 1H, H-6a), 4.02 (ddd, J = 8.4, 4.3, 1.1 Hz, 
1H, H-4), 3.74 – 3.71 (m, 1H, H-6b), 3.70 (d, J = 1.6 Hz, 1H, H-2). 13C NMR (101 MHz, (CD3)2CO) δ 167.5 
(C=O), 143.8 (C=O), 133.7 (Ph-CH), 130.4 (Ph-CH), 129.3 (Ph-CH), 129.2 (Ph-CH), 103.1 (C-1), 79.2 (C-




96: Rf in 100% EtOAc is 0.68. m.p. 90-93°C. 1H NMR (400 MHz, (CD3)2CO) δ 8.09 – 8.01 (m, 6H, Ph-H), 
7.65 – 7.60 (m, 3H, Ph-H), 7.53 – 7.51 (m, 6H, Ph-H), 5.65 (d, J = 8.6 Hz, 1H, H-3), 5.61 (d, J = 1.6 Hz, 1H, 
H-1), 5.10 (dd, J = 8.7, 1.8 Hz, 1H, H-2), 4.66 (t, J = 4.5 Hz, 1H, H-5), 4.34 (dd, J = 7.8, 0.8 Hz, 1H, H-6a), 
4.25 (ddd, J = 8.5, 4.4, 1.1 Hz, 1H, H-4), 3.85 – 3.80 (m, 1H, H-6b). 13C NMR (101 MHz, (CD3)2CO) δ 167.5 
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(C=O), 160.7 (C=O), 143.8 (C=O), 133.7 (Ph-C), 130.4 (Ph-C), 129.3 (Ph-C), 100.1 (C-1), 76.7 (C-5), 76.2 
(C-2), 75.2 (C-3), 70.6 (C-4), 66.0 (C-6). HRMS calcd for C27H22O8: 474.1315 found: 371.1134 [M-Bz]. 
 
Attempted synthesis of 1,6-Anhydro-2-O-benzyl--L-idopyranose63 (98) 
 
Triol 58 (0.18 g, 1.13 mmol) and Bu2SnO (0.31 g, 1.24 mmol) were dissolved in anhydrous PhCH3             
(40 mL) and refluxed at 110°C under Ar for 2 h after which DMF (1 mL) was added to improve solubility. 
This mixture was refluxed for a further 2 h after which all the solvent was removed under high pressure 
vacuum. The reaction mixture was then re-dissolved in PhCH3 (4 mL), and BnBr  
(0.16 mL, 1.36 mmol) and TBABr (0.18 g, 0.57 mmol) were added to the reaction under Ar. This was 
then heated at 98°C for 8 h. The reaction mixture was purified directly by flash column chromatography 
in a gradient from 20 to 65% EtOAc in hexane as eluent.1,6-Anhydro-3-O-benzyl--L-idopyranose (59) 
(0.03 g, 30.0 %) was obtained pure as a white solid. The next two products 1,6-anhydro-2-O-benzyl--
L-idopyranose (98) and 1,6-anhydro-4-O-benzyl--L-idopyranose (97) (0.13 g, 44.3 %) were eluted as 
an inseparable mixture and recovered as a white powder after drying. 
 
98: Rf in 50% EtOAc/hexane run twice is 0.19.m.p. 66-70°C. 1H NMR (400 MHz, (CD3)2CO) δ 7.42 – 7.37 
(m, 2H, Ph-H), 7.36 – 7.30 (m, 2H, Ph-H), 7.30 – 7.24 (m, 1H, Ph-H), 5.33 (d, J = 1.7 Hz, 1H, H-1),  
4.80 – 4.67 (AB q, J = 11.8 Hz, 2H, Ph-CH2), 4.54 (d, J = 3.6 Hz, 1H, 4-OH), 4.52 (td, J = 4.4, 0.8 Hz, 1H, H-
5), 4.43 (d, J = 5.2 Hz, 1H, 3-OH), 3.94 (dd, J = 7.4, 0.8 Hz, 1H, H-6a), 3.67 – 3.61 (m, 1H, H-3),  
3.61 – 3.56 (m, 1H, H-6b), 3.53 (ddd, J = 8.1, 4.1, 1.1 Hz, 1H, H-4), 3.28 (dd, J = 8.2, 1.7 Hz, 1H, H-2).13C 
NMR (101 MHz, (CD3)2CO) δ 140.1 (Ph-C), 129.04(Ph-CH), 128.4 (Ph-CH), 128.2 (Ph-CH), 100.7 (C-1), 





97: Rf in 50% EtOAc/hexane run twice is 0.19.m.p. 66-70°C. 1H 
NMR (400 MHz, (CD3)2CO) δ 7.42 – 7.37 (m, 2H, Ph-H), 7.36 – 7.30 (m, 2H, Ph-H), 7.30 – 7.24 (m, 1H, Ph-
H), 5.16 (d, J = 1.9 Hz, 1H, H-1), 4.80 – 4.67 (AB q, J =11.8 Hz, 2H, Ph-CH2), 4.43 (d, J = 5.2 Hz, 1H,  
3-OH), 4.33 (td, J = 3.9, 0.7 Hz, 1H, H-5), 4.13 (d, J = 4.4 Hz, 1H, 2-OH), 3.99 (dd, J = 7.4, 0.8 Hz, 1H,  
H-6a), 3.67 – 3.61 (m, 2H, H-4 and H-3), 3.61 – 3.56 (m, 1H, H-6b), 3.36 (td, J = 6.2, 1.7 Hz, 1H, H-2).13C 
NMR (101 MHz, (CD3)2CO) δ 139.9 (Ph-C), 128.9 (Ph-CH), 128.4 (Ph-CH), 128.1 (Ph-CH), 103.0 (C-1), 






NaH, 60% mineral oil dispersion, (0.90 g, 22.5 mmol) and compound 69 (3.66 g, 15.1 mmol) were 
dissolved in DMF (10 mL) at 0°C under Ar and stirred for 10 min. BnBr (1.96 mL, 16.5 mmol) was added 
to the reaction, the ice bath removed and the reaction stirred at RT for 18 h. The reaction mixture was 
quenched with MeOH (20 mL) and concentrated under reduced pressure. The residue was taken up in 
water (50 mL), extracted with DCM (5 x 50 mL), dried over anhydrous Na2SO4 and concentrated. The 
crude product was purified by flash chromatography in a solvent gradient from 20 to 70% EtOAc in 
hexane affording 2-methyl-(3-O-benzyl-1,2-dideoxy-5,6-O-isopropylidene--D-glucofurano)-[2,1-d]-2-




Rf in 65% EtOAc/hexane is 0.45. m.p. 102-105°C. 1H NMR (300 MHz, CDCl3) δ 7.39 – 7.23 (m, 5H, 
 Ph-H), 6.12 (d, J = 5.1 Hz, 1H, H-1), 4.71 (AB quartet, J = 11.8 Hz, 2H, Ph-CH2), 4.51 (dd, J = 5.1, 1.5 Hz, 
1H, H-2), 4.36 (dd, J = 13.0, 6.0 Hz, 1H, H-5), 4.10 (m, 1H, H-3) 4.05 (m, 1H, H-6a), 4.00 (dd, J = 8.6,  
5.7 Hz, 1H, H-6b), 3.84 (dd, J = 7.1, 3.1 Hz, 1H, H-4), 2.01 (d, J = 1.5 Hz, 3H, NC(CH3)O), 1.40 (d,  
J = 0.7 Hz, 3H, C(CH3)2), 1.35 (d, J = 0.7 Hz, 3H, C(CH3)2). 13C NMR (101 MHz, CDCl3) δ 167.1 (C(CH3)2), 
137.6 (NC(CH3)O), 128.4 (Ph-CH), 127.8 (Ph-CH), 127.7 (Ph-CH), 109.0 (Ph-C), 107.1 (C-1), 81.6 (C-4), 
75.3 (C-2), 72.6 (C-3), 72.2 (C-5), 67.0 (C-6), 26.7 (C(CH3)2), 25.3 (C(CH3)2), 14.1 (NC(CH3)O). HRMS calcd 





Oxazoline 102 (6.35 g, 19.1 mmol) was dissolved in H2O (25 mL) and heated under reflux for 18 h. The 
reaction mixture was extracted with Et2O (3 x 50 mL), dried over Na2SO4 and concentrated. This 
intermediate was dried for 4 h before continuing (Rf in 20% MeOH/EtOAc is 0.51). Ac2O (7.09 mL,        
75.2 mmol) and DMAP (0.46 g, 3.76 mmol) were added to a solution of the intermediate (6.61 g,             
18.8 mmol) in freshly distilled DCM (40 mL). The reaction mixture was stirred at RT for 17 h after which 
TLC showed all the starting material had been consumed. The reaction was quenched with NaHCO3(aq), 
extracted with DCM (5 x 35 mL), dried over anhydrous Na2SO4 and concentrated.NMR of the crude 
product, a dark yellow syrup, confirmed the formation of the desired product, 2-acetamido-O-acetyl-2-
deoxy-3-O-benzyl-5,6-O-ispropylidene--D-glucofuranose (103) (7.11 g, 94.8%).  
 
Rf in 10% MeOH/EtOAc is 0.41. 1H NMR (300 MHz, CDCl3) δ 7.37 – 7.30 (m, 5H, Ph-H), 6.35 (d,  
J = 5.4 Hz, 1H, H-1), 5.82 (d, J = 7.7 Hz, 1H, NHCOCH3), 4.71 (AB quartet, J = 4.5 Hz, 2H, Ph-CH2),  
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4.69 – 4.62 (m, 2H, H-2), 4.37 (q, J = 6.3 Hz, 1H, H-5), 4.23 (t, J = 5.4 Hz, 1H, H-4), 4.07 (dd, J = 8.6,  
6.3 Hz, 1H, H-6a), 4.01 (dd, J = 5.1, 3.6 Hz, 1H, H-3), 3.95 (dd, J = 8.7, 6.1 Hz, 1H, H-6b), 2.09 (s, 3H, 
OCOCH3), 2.00 (s, 3H, NHCOCH3), 1.40 (s, 3H, CH3), 1.35 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3) δ 169.7 
(NHCOCH3), 169.0 (OCOCH3), 137.1 (Ph-C), 128.4 (Ph-CH), 127.9 (Ph-CH), 127.8 (Ph-CH), 109.0 
(C(CH3)2), 94.6 (C-1), 81.9 (C-3), 80.5 (C-4), 73.3 (C-5), 72.2 (Ph-CH2), 66.5 (C-6), 57.1 (C-2),                       
26.7 (C(CH3)2), 25.4 (C(CH3)2), 23.3 (NHCOCH3), 21.2 (OCOCH3). HRMS calcd for C20H27NO7: 393.1788; 




Compound 103 (7.11 g, 18.1 mmol) was dissolved in 70% aqueous AcOH (90 mL) and stirred at RT for 
18 h. It was quenched with aqueous NaHCO3 and cooled in an ice bath before being extracted with DCM 
(5 x 50 mL), dried over anhydrous Na2SO4 and concentrated under reduced pressure. The residue was 
purified by column chromatography in a gradient solvent system from 100% EtOAc a 15% MeOH/EtOAc 
mixture. The desired product, 2-acetamido-O-acetyl-2-deoxy-3-O-benzyl--D-glucofuranose (104) was 
afforded as a yellow foam (4.46 g, 71.1%). 
 
Rf in 15% MeOH/EtOAc is 0.33. m.p. 25-26°C. 1H NMR (600 MHz, CDCl3) δ 7.38 – 7.31 (m, 5H, Ph-H), 6.32 
(d, J = 5.3 Hz, 1H, H-1), 5.84 (d, J = 8.2 Hz, 1H,NHCOCH3), 4.85 (d, J = 11.7 Hz, 1H, Ph-CH2), 4.79 (ddd, J = 
8.3, 5.3, 4.1 Hz, 1H, H-2), 4.59 (d, J = 11.8 Hz, 1H,Ph-CH2), 4.20 (dd, J = 8.1, 5.8 Hz, 1H, H-4), 4.16 (dd, J = 
5.8, 4.1 Hz, 1H, H-3), 3.97 (ddd, J = 8.3, 5.1, 3.5 Hz, 1H, H-5), 3.78 (dd, J = 11.5, 3.4 Hz, 1H, H-6a), 3.66 (dd, 
J = 11.5, 5.2 Hz, 1H, H-6b), 2.11 (s, 3H, OCOCH3), 2.03 (s, 3H,NHCOCH3). 13C NMR  
(101 MHz, CDCl3) δ 169.6 (NHCOCH3), 169.1 (OCOCH3), 137.1 (Ph-C), 128.9 (Ph-CH), 128.4  
(Ph-CH), 128.2 (Ph-CH), 94.6 (C-1), 82.3 (C-3), 78.6 (C-4), 72.1 (Ph-CH2), 70.0 (C-5), 63.8  
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(C-6), 56.7 (C-2), 23.4 (NHCOCH3), 21.2 (OCOCH3). 1H NMR (600 MHz, (CD3)2CO) δ 7.42 (d,  
J = 8.4 Hz, 1H, NHCOCH3), 7.39 (ddd, J = 8.0, 1.9, 1.3 Hz, 2H, Ph-H), 7.36 – 7.31 (m, 2H, Ph-H),  
7.32 – 7.24 (m, 1H, Ph-H), 6.29 (d, J = 5.4 Hz, 1H, H-1), 4.82 (d, J = 11.7 Hz, 1H, Ph-CH2), 4.76 (ddd,  
J = 8.6, 5.4, 3.3 Hz, 1H, H-2), 4.66 (d, J = 11.7 Hz, 1H, Ph-CH2), 4.23 – 4.16 (m, 2H, H-3 and H-4), 3.95 (bs, 
1H, H-5), 3.74 – 3.68 (m, 2H, H-6a), 3.58 – 3.52 (m, 1H. H-6b), 2.03 (s, 3H, OCOCH3), 1.93 (d, J = 0.8 Hz, 
3H, NHCOCH3). 13C NMR (101 MHz, (CD3)2CO) δ 170.0 (NHCOCH3), 169.8 (OCOCH3), 139.3 (Ph-C), 129.13 
(Ph-CH), 128.6 (Ph-CH), 128.3 (Ph-CH), 95.4 (C-1), 83.4 (C-3), 80.2 (C-4), 72.5 (Ph-CH2), 70.4 (C-5), 64.47 







Optimised route: TBDMSCl (1.10 g, 7.31 mmol) was dissolved in anhydrous pyridine (10 mL) under Ar. 
This solution was added to diol 104 (2.58 g, 7.31 mmol) and stirred at RT for 24 h. Another equivalent 
of TBDMSCl (1.10 g, 7.31 mmol) was added to the reaction using 6 mL pyridine and stirred for a further 
24 h at RT. The reaction was washed with brine and extracted with DCM (3 x 50 mL), dried over Na2SO4 
and concentrated. Residual pyridine was removed azeotropically using PhCH3. No further purification 
was necessary. NMR confirmed that the white powder was the desired product, 2-acetamido-O-acetyl-




Rf in 5% MeOH/EtOAc is 0.54. m.p. 116-120°C. 1H NMR (400 MHz, CDCl3) δ 7.40 – 7.32 (m, 5H, Ph-H), 
6.37 (d, J = 5.6 Hz, 1H, H-1), 5.73 (d, J = 8.0 Hz, 1H, NHCOCH3), 4.85 (d, J = 12.0 Hz, 1H, Ph-CH2), 4.74 (ddd, 
J = 8.4, 5.6, 3.1 Hz, 1H, H-2), 4.67 (d, J = 11.9 Hz, 1H, Ph-CH2), 4.15 (dd, J = 7.9, 5.1 Hz, 1H, H-4), 4.08 (dd, 
J = 5.1, 3.2 Hz, 1H, H-3), 4.00 (dd, J = 8.2, 3.7 Hz, 1H, H-5), 3.79 (dd, J = 10.4, 3.6 Hz, 1H, H-6a), 3.73 (dd, J 
= 10.3, 4.8 Hz, 1H, H-6b), 2.72 (d, J = 6.0 Hz, 1H, 5-OH), 2.10 (s, 3H, OCOCH3), 2.02 (s, 3H, NHCOCH3), 0.89 
(s, 9H, OSi(CH3)2C(CH3)3), 0.05 (s, 6H, OSi(CH3)2C(CH3)3). 13C NMR (101 MHz, CDCl3) δ 169.4 (NHCOCH3), 
168.9 (OCOCH3), 137.7 (Ph-C), 128.6 (Ph-CH), 128.1 (Ph-CH), 128.0 (Ph-CH), 94.7 (C-1), 82.7 (C-3), 79.1 
(C-4), 72.15(Ph-CH2), 69.3 (C-5), 64.1 (C-6), 57.3 (C-2), 26.0 (OSi(CH3)2C(CH3)3), 23.4 (NHCOCH3), 21.2 
(OCOCH3), 18.5 (OSi(CH3)2C(CH3)3), -5.3 (OSi(CH3)2C(CH3)3). 1H NMR (400 MHz, (CD3)2CO) δ 7.38 (d, J = 
8.4 Hz, 1H, NHCOCH3), 7.41 – 7.24 (m, 5H, Ph-H), 6.31 (d, J = 5.5 Hz, 1H, H-1), 4.82 (d, J = 11.9 Hz, 1H, Ph-
CH2), 4.75 (ddd, J = 8.8, 5.5, 3.6 Hz, 1H, H-2), 4.65 (d, J = 11.8 Hz, 1H, Ph-CH2), 4.22 (dd, J = 7.9, 5.4 Hz, 1H, 
H-4), 4.17 (dd, J = 5.4, 3.7 Hz, 1H, H-3), 4.00 – 3.92 (m, 1H, H-5), 3.83 (dd, J = 10.5, 3.0 Hz, 1H, H-6a), 3.75 
– 3.69 (m, 1H, H-6b), 3.55 (d, J = 5.9 Hz, 1H, 5-OH), 2.02 (s, 3H, OCOCH3), 1.92 (s, 3H, NHCOCH3), 0.90 (s, 
9H, OSi(CH3)2C(CH3)3), 0.06 (d, J = 0.4 Hz, 6H, OSi(CH3)2C(CH3)3). 13C NMR (101 MHz, (CD3)2CO) δ 169.8 
(NHCOCH3), 169.7 (OCOCH3), 139.4 (Ph-C), 129.1 (Ph-CH), 128.6 (Ph-CH), 128.3 (Ph-CH), 95.3 (C-1), 
83.5 (C-3), 79.9 (C-4), 72.5 (Ph-CH2), 70.3 (C-5), 65.6 (C-6), 58.4 (C-2), 26.3 (OSi(CH3)2C(CH3)3), 22.8 
(NHCOCH3), 21.0 (OCOCH3), 19.0 (OSi(CH3)2C(CH3)3), -5.1 (OSi(CH3)2C(CH3)3). HRMS calcd for 
C23H37NO7Si: 467.2339; found: 408.2206 [M-OAc]. 
 
Attempted synthesis of 1,6-anhydro-2-acetamido-O-acetyl-2-deoxy-3-O-benzyl--
D-glucofuranose (106) 
 
Method 1: Diol 104 (0.26 g, 0.72 mmol) was dissolved in DCM (10 mL) at RT under Ar. DMAP (0.02 g, 
0.14 mmol) was added with the reaction and stirred at RT for 10 mins. TBDMSCl (0.120 g,  
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0.79 mmol) was then added to the reaction and allowed to stir for a 24 hours. Another 0.2 equivalents 
of DMAP was added. After a further 24 hours at RT reaction mixture was washed with water and back 
extracted with DCM (3 x 35 mL). The combined organic layers were dried over anhydrous Na2SO4 and 
concentrated under reduced pressure. This residue was purified by flash column chromatography in a 
gradient solvent system from 70% to 100% EtOAc in hexane. The product was afforded as a pale yellow 
solid identified as a mixture of two products by NMR. A second purification separated the two products. 
The major product was identified as 2-acetamido-O-acetyl-2-deoxy-3-O-benzyl-6-O-t-
butyldimethylsilyl--D-glucofuranose (35) (0.160 g, 47.2%) and the minor product was 1,6-anhydro-2-
acetamido-O-acetyl-2-deoxy-3-O-benzyl--D-glucofuranose (38) (0.02 g, 10.1%). 
 
Method 2: Diol 104 (0.17 g, 0.49 mmol) was dissolved in freshly distilled DCM (8 mL). DMAP (0.12 g, 
0.99 mmol) was added with the reaction stirred at RT for 20 hours. TLC showed no reaction had 
occurred. Some reaction appeared to be taking place but there was still residual starting material. The 
reaction mixture was washed with water and back extracted (5 x 35 mL) with DCM. The combined 
organic layers were dried of Na2SO4 and concentrate under reduced pressure. NMR of the crude material 
was checked and only starting material was recovered (0.17 g, 97.1%).71 
 
Method 3: 104 (0.16 g, 0.45 mmol) was dissolved in anhydrous THF (10 mL). NaH (0.03 g, 0.91 mmol) 
was added with the reaction and stirred at room temperature for 18 hours. TLC showed a more polar 
spot and the disappearance of all the starting material. Ac2O (0.17 mL, 1.81 mmol) was added to the 
reaction mixture and stirred for 17 hours after. The reaction mixture was washed with brine and back 
extracted with EtOAc (3 x 35 mL). The combined organic layers were dried over Na2SO4 and 
concentrated under reduced pressure. This residue was purified by flash column chromatography in a 
gradient solvent system from 100% EtOAc to 2% MeOH/EtOAc. The product was afforded as a white 
yellow solid and identified by NMR as 2-acetamido-1,5,6-tri-O-acetyl-2-deoxy-3-O-benzyl--D-





Rf in 5% MeOH/EtOAc is 0.48. 1H NMR (300 MHz, CDCl3) δ 7.43 – 7.30 (m, 5H, Ph-H), 5.74 (d, J = 8.6 Hz, 
1H, H-1), 5.47 (d, J = 9.0 Hz, 1H, NHCOCH3), 4.87 – 4.71 (m, 2H, Ph-CH2), 4.57 – 4.49 (m, 1H), 4.37 (t, 
 J = 7.0 Hz, 1H), 4.27 (dd, J = 12.4, 1.5 Hz, 1H), 4.03 – 3.85 (m, 1H), 3.73 – 3.61 (m, 1H), 3.58 (d,  
J = 2.2 Hz, 1H), 2.13 (s, 3H, OCOCH3), 2.10 (s, 3H, OCOCH3), 2.09 (s, 3H, NHCOCH3), 1.88 (s, 3H, OCOCH3).  
 
Method 4: 104 (0.17 g, 0.48 mmol) was dissolved in DCM (10 mL) under Ar. TMSOTf (0.09 mL,  
0.49 mmol) was added to the reaction mixture and stirred at room temperature for 4 hours. The reaction 
was quenched with aqueous NaHCO3 and extracted with DCM (3 x 35 mL) and dried over anhydrous 
Na2SO4.The residue was purified by column chromatography in a gradient solvent system from 100% 
EtOAc to 8% MeOH/EtOAc from which two products were eluted. The major product was deacetylated 
starting material, 2-acetamido-2-deoxy-3-O-benzyl--D-glucofuranose (0.05 g, 29.7%). The minor 
product was the desired 1,6-anhydro-2-acetamido-O-acetyl-2-deoxy-3-O-benzyl--D-glucofuranose 
(38) (0.02 g, 12.1%) although it was still impure even after purification by column chromatography. 
 
106: Rf in 8% MeOH/EtOAc is 0.36. 1H NMR (300 MHz, CDCl3) δ 7.41 – 7.26 (m, 5H, Ph-H), 5.76 (d,  
J = 8.8 Hz, 1H, NHCOCH3), 5.03 (s, 1H, H-1), 4.82 (d, J = 12.0 Hz, 1H, PhCH2), 4.72 (dd, J = 8.7, 2.5 Hz, 1H, 
H-2), 4.57 (d, J = 12.0 Hz, 1H, PhCH2), 4.41 (dt, J = 9.8, 2.5 Hz, 2H, H-4), 4.41 (dt, J = 9.8, 2.5 Hz, 2H,  
H-6a), 3.97 (ddd, J = 6.8, 2.5, 0.9 Hz, 1H, H-3), 3.82 (dt, J = 12.7, 1.3 Hz, 1H, H-6b), 3.72 (tt, J = 2.3,  
0.9 Hz, 1H, H-5), 2.01 (s, 3H).13C NMR (101 MHz, CDCl3) δ 128.6 (Ph-CH), 128.2 (Ph-CH), 127.8  




Rf in 8% MeOH/EtOAc is 0.33. 1H NMR (300 MHz, CDCl3) δ 7.38 – 7.32 (m, 5H, Ph-H), 6.18 (d, J = 4.8 Hz, 
1H, H-1), 4.77 (d, J = 11.8 Hz, 1H, Ph-CH2), 4.59 (d, J = 11.9 Hz, 1H, PhCH2),  4.59 (d, J = 11.9 Hz, 2H,  
H-2), 4.19 (d, J = 3.1 Hz, 1H), 4.04 (ddd, J = 8.3, 5.3, 3.3 Hz, 1H), 3.83 (s, 1H), 3.78 (d, J = 3.4 Hz, 1H), 3.67 
(dd, J = 11.4, 5.4 Hz, 1H), 2.04 (s, 3H, NHCOCH3). 
 
Method 5: 104 (0.43 g, 1.20 mmol) was dissolved in DCM (12 mL) under Ar at RT. BF3Et2O  
(0.01 mL, 0.12 mmols) was added to the reaction mixture and stirred at RT for 20 hours. No progress 
was clear from TLC so more BF3.Et2O (0.07 mL, 0.60 mmol) was added. After 8 hours the reaction was 
worked up in aqueous NaHCO3 and extracted with DCM (3 x 35 mL) and dried over anhydrous Na2SO4. 
No further purification was done. NMR of the crude product showed a mixture of the desired 1,6-
anhydro-2-acetamido-O-acetyl-2-deoxy-3-O-benzyl--D-glucofuranose (106) and starting material 
(104) (0.29 g). 
 
Method 6: 104 (0.05 g, 0.14 mmol) was dissolved in DCM under Ar. SnCl4 (0.019 mL, 0.17 mmol) was 
added dropwise to the reaction mixture with vigorous stirring which then stirred at RT for  
2 h. TLC showed no reaction, therefore equivalent of SnCl4 (0.02 mL, 0.17 mmol) was added and the 
reaction stirred for a further 18 hours. TLC appeared to indicate that all the starting material had been 
consumed. The reaction was therefore diluted with DCM, cold aqueous NaHCO3 added and stirred for 
30 mins. This was extracted with DCM (3 x 30 mL), dried over anhydrous Na2SO4 and concentrated. The 
residue was purified by column chromatography in a solvent gradient from 100% EtOAc to 10% MeOH 
in EtOAc. A single spot was eluted and isolated as a yellow solid which was identified as a mixture of the 
desired 1,6-anhydro-2-acetamido-O-acetyl-2-deoxy-3-O-benzyl--D-glucofuranose (106) and starting 




Method 7: 105 (0.05 g, 0.11 mmol) was dissolved in DCM (8 mL) under Ar. TMSOTf (0.004 mL,                 
0.02 mmol) was added to the reaction and stirred at room temperature for 48 hours until the reaction 
appeared complete on TLC. It was quenched with aqueous NaHCO3 and extracted with DCM (3 x 20 mL), 
dried over anhydrous Na2SO4 and concentrated. The residue was purified by column chromatography 
in a solvent system from 100% EtOAc to 8% MeOH in EtOAc. Three separate products were collected. 
Recovered starting material (0.02 g, 43.3%), the desired 1,6-anhydro-2-acetamido-O-acetyl-2-deoxy-3-
O-benzyl--D-glucofuranose (106) (0.008 g, 26.0%) and 2-acetamido-O-acetyl-2-deoxy-3-O-benzyl--
D-glucofuranose (104) the TBDMS protecting group having been removed from O-6 (0.008 g, 22.1%). 
Rf’s in 5% MeOH/EtOAc are 0.63, 0.37 and 0.27 respectively. 
 
Attempted synthesis of 2-Acetamido-O-acetyl-2-deoxy-3-O-benzyl-6-O-t-
butyldimethylsilyl-5-O-triflate--D-glucofuranose59 (107) 
 
Method 1: General method, see Table 4 for details. 105 was dissolved in anhydrous pyridine under Ar. 
Tf2O was added to the reaction mixture and stirred at a variety of temperatures. Once TLC indicated that 
all the starting material had been consumed the reaction was quenched with H2O and extracted with 
EtOAc. The organic layer was washed sequentially with dilute HCl, saturated NaHCO3 and brine. The 
organic layer was dried over anhydrous Na2SO4, concentrated and dried under reduced pressure. No 
further purification was carried out due to the sensitivity of triflates on silica gel, as observed on TLC 
while monitoring the reaction. NMR of the crude material showed a single carbohydrate product which 
was identified as 2-acetamido-O-acetyl-2-deoxy-3-O-benzyl-6-O-t-butyldimethylsilyl-5-O-pyridine--D-




Rf in 80% EtOAc/hexane is 0.12. 1H NMR (400 MHz, CDCl3) δ 8.92 (dd, J = 6.8, 1.2 Hz, 2H, py), 8.36 (tt,  
J = 7.8, 1.3 Hz, 1H, py), 7.88 (dd, J = 7.7, 6.9 Hz, 2H, py), 7.37 – 7.31 (m, 5H, Ph-CH), 7.30 (d, J = 1.9 Hz, 2H, 
NHCOCH3), 6.33 (d, J = 5.6 Hz, 1H, H-1), 5.14 (dd, J = 8.0, 4.0 Hz, 1H, H-4), 4.99 – 4.90 (m, 1H, H-5), 4.85 
(ddd, J = 8.8, 5.6, 1.6 Hz, 1H, H-2), 4.77 (d, J = 11.1 Hz, 1H, Ph-CH2), 4.54 (dd, J = 11.6, 3.6 Hz, 1H, Ph-CH2), 
4.23 (dd, J = 4.0, 1.7 Hz, 1H, H-3), 4.05 (dd, J = 11.5, 9.8 Hz, 1H, H-6a), 3.91 (dd, J = 11.5, 4.0 Hz, 1H, H-
6b), 2.10 (s, 3H, OCOCH3), 2.07 (s, 3H, NHCOCH3), 0.65 (s, 9H,OSi(CH3)2C(CH3)3), -0.08 (s, 3H, 
OSi(CH3)2C(CH3)3), -0.19 (s, 3H, OSi(CH3)2C(CH3)3). 13C NMR (101 MHz, CDCl3) δ 170.8 (NHCOCH3), 169.9 
(OCOCH3), 145.6 (py), 144.9 (py), 136.6 (Ph-C), 129.0 (Ph-CH), 128.8 (Ph-CH), 128.6 (Ph-CH), 127.6 (py), 
122.3 (q, J = 379.6, 296.7 Hz, CF3), 94.2 (C-1), 82.4 (C-3), 76.9 (C-4), 74.9 (C-5), 71.8 (Ph-CH2), 61.6 (C-
6), 56.3 (C-2), 25.5 (OSi(CH3)2C(CH3)3), 22.9 (NHCOCH3), 21.0 (OCOCH3), 17.9 (OSi(CH3)2C(CH3)3), -5.6 
(OSi(CH3)2C(CH3)3), -5.8 (OSi(CH3)2C(CH3)3). 19F NMR (377 MHz, CDCl3) δ -78.2 (s, 3F, OSO2CF3). HRMS 
calcd for C28H41N2O6Si: 529.2736; found: 529.2735 [M+H+]. 
 
Method 2: The method described above was attempted using different solvents namely; a catalytic 
amount of DMAP in DCM, 2,6-lutidine, NMM and THF. The reactions in 2,6-lutidine and NMM did not 
progress and all the starting material was recovered. The DCM and THF reactions recovered no 






Silyl ether 105 (0.10 g, 0.21 mmol) was dissolved in anhydrous pyridine (3 mL) under Ar. Ac2O (0.03 
mL, 0.33 mmol) was added to the reaction mixture and stirred at RT for 24 h. No reaction was occurring 
therefore a further portion of Ac2O (0.09 mL, 0.98 mmol) was added to the reaction and the temperature 
was increased to 60°C for 18 h. The reaction was washed with water and extracted with DCM (3 x               
30 mL), dried over Na2SO4 and concentrated. NMR of the crude product indicated that no further 
purification was needed and confirmed that the dark yellow syrup was the  
desired 2-acetamido-1,5-di-O-acetyl-2-deoxy-3-O-benzyl-6-O-t-butyldimethylsilyl--D-glucofuranose 
(109) (0.099 g, 90.8%). 
 
Rf in 100% EtOAc is 0.54. 1H NMR (400 MHz, CDCl3) δ 7.32 (s, 5H, Ph-H), 6.39 (d, J = 5.6 Hz, 1H, H-1), 
5.74 (d, J = 7.5 Hz, 1H, NHCOCH3), 5.22 – 5.10 (m, 1H, H-5), 4.78 (d, J = 12.0 Hz, 1H, Ph-CH2), 4.72 – 4.66 
(m, 1H, H-2), 4.62 (d, J = 12.1 Hz, 1H, Ph-CH2), 4.40 (dd, J = 7.5, 4.9 Hz, 1H, H-4), 3.96 (dd, J = 5.0, 2.8 Hz, 
1H, H-3), 3.92 (d, J = 2.3 Hz, 1H, H-6a), 3.81 (dd, J = 11.5, 4.3 Hz, 1H, H-6b), 2.10 (s, 3H, 1-OCOCH3), 2.03 
(s, 3H, NHCOCH3), 1.91 (s, 3H, 5-OCOCH3), 0.87 (s, 9H,OSi(CH3)2C(CH3)3), 0.01 (d, J = 1.2 Hz, 6H, 
OSi(CH3)2C(CH3)3). 13C NMR (101 MHz, CDCl3) δ 169.9 (5-OCOCH3), 169.5 (NHCOCH3), 168.8  
(1-OCOCH3), 137.6 (Ph-C), 128.5 (Ph-CH), 128.4 (Ph-CH), 127.9 (Ph-CH), 94.6 (C-1), 81.6 (C-3), 77.4 (C-
4), 71.9 (C-5), 71.6 (Ph-CH2), 61.6 (C-6), 57.0 (C-2), 25.9 (OSi(CH3)2C(CH3)3), 23.4 (NHCOCH3), 21.1 (1-
OCOCH3), 21.1 (5-OCOCH3), 18.4 (OSi(CH3)2C(CH3)3), -5.3 (OSi(CH3)2C(CH3)3). HRMS calcd for 







Silyl ether 105 (0.33 g, 0.70 mmol) was dissolved in anhydrous pyridine (3 mL) under Ar and cooled to 
-10°C. MsCl (0.11 mL, 1.40 mmol) was added to 3 mL anhydrous pyridine and this mixture added to the 
carbohydrate mixture dropwise. The reaction was stirred for 4 hours while the ice/acetone bath 
warmed to RT. The reaction was cooled to -10°C and another equivalent of MsCl added and stirred for a 
further 4 h. The reaction was then diluted with EtOAc and the solid filtered off through filter paper. The 
filtrate was then washed sequentially with dilute HCl, saturated aqueous NaHCO3 and brine. The organic 
layer was dried over anhydrous Na2SO4 and concentrated under reduced pressure. This residue was 
purified by flash chromatography in a gradient solvent system from 50 to 100%  
EtOAc in Hexane. 2-acetamido-O-acetyl-2-deoxy-3-O-benzyl-6-O-t-butyldimethylsilyl-5-O-mesyl--D-
glucofuranose (111) (0.23 g, 60.5%) was afforded as a light yellow syrup.  
 
Rf in 80% EtOAc/Hexane is 0.33. 1H NMR (400 MHz, CDCl3) δ 7.38 – 7.27 (m, 5H, Ph-H), 6.36 (d,  
J = 5.6 Hz, 1H, H-1), 5.76 (d, J = 7.9 Hz, 1H, NHCOCH3), 4.94 (ddd, J = 6.7, 4.5, 2.2 Hz, 1H, H-5), 4.84 (d,  
J = 11.7 Hz, 1H, Ph-CH2), 4.71 (ddd, J = 8.1, 5.6, 3.4 Hz, 1H, H-2), 4.62 (d, J = 11.7 Hz, 1H, Ph-CH2),  
4.52 – 4.45 (m, 1H, H-4), 4.14 – 4.07 (m, 1H, H-3), 4.04 (dd, J = 11.9, 2.3 Hz, 1H, H-6a), 3.88 (dd,  
J = 11.9, 6.6 Hz, 1H, H-6b), 3.01 (s, 3H, Ms-CH3), 2.11 (s, 3H, OCOCH3), 2.02 (s, 3H, NHCOCH3), 0.88 (s, 9H, 
OSi(CH3)2C(CH3)3), 0.03 (d, J = 3.5 Hz, 6H, OSi(CH3)2C(CH3)3).13C NMR (101 MHz, CDCl3) δ 169.5 
(NHCOCH3), 168.9 (OCOCH3), 137.4 (Ph-C), 128.6 (Ph-CH), 128.2 (Ph-CH), 128.1 (Ph-CH), 94.2 (C-1), 
82.1 (C-3), 81.6 (C-5), 79.5 (C-4), 72.2 (Ph-CH2), 62.4 (C-6), 57.0 (C-2), 38.6 (Ms-CH3), 25.9 
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(OSi(CH3)2C(CH3)3), 23.4 (NHCOCH3), 21.1 (OCOCH3), -5.3 (OSi(CH3)2C(CH3)3). HRMS calcd for C24H-
39NO9SSi: 545.2115; found: 546.2212 [M+H]. 
 
Attempted synthesis of 2-Acetamido-O-acetyl-2-deoxy-3-O-benzyl-5-O-benzoyl-6-
O-t-butyldimethylsilyl--L-idofuranose (108) 
 
Method 1: 105 (0.09 g, 0.19 mmol) was dissolved in DMF (3 mL) and pyridine (0.03 mL,   
0.37 mmol) under Ar. The reaction mixture was cooled to -20°C and Tf2O (0.125 mL, 0.742 mmol) added 
dropwise over 30 minutes. The reaction was then stirred for two hours while allowing the ice/acetone 
bath to warm to room temperature. Once all the starting material had been consumed (as monitored by 
TLC), NaOBz (0.05 g, 0.37 mmol) was added to the reaction. It was stirred at RT for a further 6 hours. 
The reaction was diluted with EtOAc and washed sequentially with aqueous NaHCO3, 1M HCl and brine. 
The EtOAc layer was dried over anhydrous Na2SO4. This residue was purified by flash chromatography 
in a gradient solvent system from 40 to 100% EtOAc in Hexane.  A single product was eluted from the 
column with an Rf in 100% EtOAc of 0.39, 2-acetamido-O-acetyl-2-deoxy-3-O-benzyl--D-glucofuranose 
(104) (0.05 g, 78%). 
 
Method 2: 105 (0.10 g, 0.22 mmol) was dissolved in DCM (6 mL) and pyridine (0.06 mL, 0.44 mmol) 
under Ar. The reaction mixture was cooled to -20°C and Tf2O (0.15 mL, 0.88 mmol) added dropwise over 
20 minutes. The reaction was then stirred for 2 hours at that temperature. The DCM was removed on 
the schlenk line and DMF (1.5 mL) was added to round bottom flask. NaOBz (0.03 g, 0.22 mmol) in DMF 
(1 mL) was added to the reaction and stirred for 4 hours at RT. The reaction was diluted with EtOAC, 
washed with water and brine, dried over Na2SO4 and concentrated. NMR showed that no carbohydrate 
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material remained fragments of TBDMS and some aromatic peaks from the benzyl group were seen 
indicating that the compound had fragmented. This reaction was repeated to include a work up between 
the steps. After the triflation the reaction mixture was washed sequentially with aqueous NaHCO3, 1M 
HCl and brine and extracted with DCM (3 x 20 mL). This was dried over anhydrous Na2SO4, concentrated 
and the residue dissolved in DMF (2.5 mL). The second part of the reaction was carried out in the same 
way. The result was the same as the first attempt.  
 
Method 3: 110 (0.16 g, 0.31 mmol) and NaOBz (0.17 mg, 1.14 mmol) were dissolved in anhydrous 
pyridine under Ar. The reaction mixture was heated at 90°C for 24 hours. The reaction was cooled, 
washed with water and the aqueous layer extracted with Et2O (3 x 25 mL). The combined organic layers 
were back extracted with brine, dried over anhydrous Na2SO4 and concentrated. No further purification 
was done. NMR of the crude material showed complete degradation of the carbohydrate material.   
 
Method 4: 111 (0.08 g, 0.17 mmol) and NaOBz (0.08 g, 0.56 mmol) were dissolved in anhydrous pyridine 
(4 mL) under Ar. The reaction was stirred at RT 18 hours. The reaction was then diluted with EtOAc and 
the excess NaOBz filtered off through filter paper. The filtrate was washed with water and the aqueous 
layer extracted with EtOAc (3 x 25 mL). The organic layers were then back extracted with brine, dried 
over anhydrous Na2SO4 and concentrated. NMR of the crude material showed only starting material was 
recovered as a yellow syrup (0.06 g, 75%), none of the desired product had formed.  
Rf in 80% EtOAc/Hexane is 0.31. This reaction was repeated at 100°C with the same result. 
 
Method 5: 111 (0.11 g, 0.19 mmol) and NaOBz (0.11 g, 0.74 mmol) were dissolved in freshly distilled 
acetone (5 mL) under Ar. The reaction was refluxed at 60°C for 40 h after which TLC indicated no 
reaction had taken place. The reaction was then diluted with EtOAc and the excess NaOBz filtered off 
through filter paper. The collected filtrated was washed with brine, dried over anhydrous Na2SO4 and 
concentrated. NMR of the crude material showed that only starting material was recovered  




Method 6: 111 (0.10 g, 0.18 mmol) and NaOBz (0.10 g, 0.69 mmol) were dissolved in anhydrous pyridine 
(3 mL) under Ar. The reaction was heated to 60°C for 14 h after which TLC indicated no reaction was 
taking place. The temperature was then increased to 90°C and the reaction stirred for a further 24 h. 
The reaction was then diluted with EtOAc and the solid filtered off through celite. It was then washed 
sequentially with dilute HCl, saturated NaHCO3 and brine. The organic layer was dried over Na2SO4 and 
concentrated under reduced pressure.NMR of the crude material showed that only starting material was 
recovered (0.09 g, 91.4%).Rf  in 80% EtOAc/Hexane is 0.39. 
 
Method 7: Benzoic acid (0.13 g, 1.02 mmol) was dissolved in THF (2 mL) under nitrogen and cooled to -
78°C. n-Butyllithium (1.6M, 0.88 mL, 1.22 mmol) was added dropwise to the reaction mixture and 
stirred for 30 mins while warming to 0°C. The reaction was cooled to -78°C again and 111 (0.13 g,      
0.231 mmol) in THF (2 mL) was added and the reaction stirred at this temperature for 1 hour. TLC 
showed no reaction was taking place at that temperature and the reaction was warmed to 0°C for  
4 hours. The reaction was not progressing at this temperature and it was warmed to RT for a further 12 
hours. The reaction was quenched with cold NH4Cl and extracted with EtOAc (3 x 25 mL). The combined 
EtOAc layers were washed with aqueous NaHCO3 and brine, dried over anhydrous Na2SO4 and 
concentrated under reduced pressure. This residue was purified on a preparative TLC plate and three 
UV active bands collected. It was clear from their NMR spectra that these samples contained no 
carbohydrate material, indicating that the compound had degraded. 
 





111 (0.12 g, 0.23 mmol) and NaOPiv (0.12 g, 0.99 mmol) were dissolved in anhydrous DMF  
(4 mL) under Ar. The reaction was stirred at RT for 4 hours but TLC showed that no reaction was taking 
place to it was heated to 100°C and stirred at this temperature for 14 hours. The reaction was then 
cooled to room temperature and diluted with EtOAc, washed with water and the aqueous layer extracted 
with EtOAc (3 x 25 mL). The combined organic layers were then back extracted with brine, dried over 
Na2SO4 and concentrated. This residue was purified by flash chromatography in a gradient solvent 
system from 35 to 100% EtOAc in Hexane. Only one compound was eluted from the column but it was 
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